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2.1 Abstract in English 
HCN4 channels control pacemaking of the heart. They are activated by negative voltage and modulated by 
cAMP. Recently it had been discovered that cyclic di-nucleotides bind to a second site in the channel C-
terminus. This counteracts the effect of cAMP on shifting channel activation positive. A bacterial cyclase, 
which synthesizes c-di-GMP in response to red light, allows engineering of an optogenetic system for 
remote HCN4 modulation and hence for controlling the heart pace. 
Two cyclases were used in this work: one constitutively active (Slr1143) and one red ligh-regulated (BphS). 
Because the latter has some dark activity, it is co-expressed with a phosphodiesterase (YhjH). Recordings of 
HCN4 activity in HEK293T cells show that Slr1143 affects the voltage dependence of the channel, shifting 
the activation curve negative with respect to the control. 
Experiments with BphS show no difference in HCN4 activity between light and dark treated cells. The 
combined BphS-YhjH expression seemed to be unable to increase the c-di-GMP concentration in a light 
dependent manner. To examine the effect of light on c-di-GMP production we quantified the cyclic di-
nucleotide with an established ELISA assays in HEK293T cells and with an immune-fluorescence method. 
The latter consisted of monitoring expression of interferon-β in BphS-YhjH expressing T cells. Cyclic di-
nucleotides can activate the STING pathway, which augments synthesis of interferon-β. Both methods 
underlined that Slr1143 and BphS-YhjH system increased the level of c-di-GMP in cells. This activity, 
however, was not light regulated. The immuno-fluorescence data indicate a slightly higher expression 
of the constitutive compared to the  light-regulated cyclase. This may explain  why we observed an effect of 
the former but not of the latter on HCN4 gating. Eliminating YhjH did not affect the level of c-di-GMP, 
suggesting that the phosphodiesterase is insufficient for eliminating c-di-GMP dark production. The data 
confirm previous results in that c-di-GMP is able to modulate HCN4 activity. BphS is not yet suitable as an 
optogenetic tool because of its high dark activity. This problem may be overcome by increasing the 
expression/activity of the phosphodiesterase in the next iteration of engineering an optogenetic tool. 
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2.2 Abstract in italiano 
I canali HCN4 sono i principali regolatori della frequenza cardiaca. Si aprono in iperpolarizzazione e sono 
modulati da cAMP. Recentemente si è scoperto che anche i nucleotidi di-ciclici interagiscono con il canale, 
legandosi in un altro sito localizzato al C-terminale. Ciò contrasta la capacità del cAMP di spostare la 
voltaggio dipendenza verso potenziali più positivi. Una ciclasi batterica, che sintetizza c-di-GMP in risposta a 
luce rossa, permette di costruire un sistema per il controllo remoto di HCN4 e dunque del pacemaker. 
In questo lavoro sono state utilizzate due ciclasi: una costitutivamente attiva (Slr1143) ed una regolata da 
luce rossa (BphS). Dato che quest’ultima presenta attività ciclasica anche al buio, va co-espressa con una 
fosfodiesterasi (YhjH). Registrazioni delle correnti attivate da HCN4 in HEK293T, mostrano che Slr1143 
modifica la voltaggio dipendenza del canale spostandone la curva di attivazione rispetto ai controlli. 
Gli esperimenti con BphS non mostrano alcuna differenza nell’attività di HCN4 tra buio e luce. L’espressione 
combinata di BphS e YhjH sembrava non aumentare la concentrazione di c-di-GMP in modo luce-
dipendente. Per analizzare l’effetto della luce sulla produzione di c-di-GMP, esso è stato quantificato con un 
consolidato test ELISA e con immuno-fluorescenza. Quest’ultimo metodo consisteva nel monitorare 
l’espressione di interferone β in cellule T esprimenti Bphs-YhjH. I nucleotidi di-ciclici attivano infatti il 
pathway di STING, che aumenta la sintesi dell’interferone. Entrambi i metodi hanno evidenziato che 
Slr1143 e il sistema BphS-YhjH aumentavano il c-di-GMP nelle cellule. Tuttavia, questa attività non era luce-
dipendente. I dati di immuno-fluorescenza indicano un’espressione leggermente maggiore della ciclasi 
costitutiva rispetto a quella luce-regolata. Ciò può spiegare perché abbiamo osservato un effetto del primo 
costrutto sul gating di HCN4 ma non del secondo. L’eliminazione della fosfodiesterasi YhjH non aumenta la 
concentrazione finale di c-di-GMP e ciò indica che essa non è in grado di compensarne la produzione al 
buio. I dati confermano osservazioni precedenti sulla capacità del c-di-GMP di modulare l’attività di HCN4. 
Tuttavia BphS non è ancora adatto per essere usato in optogenetica per via della sua attività al buio. 
Questo problema potrebbe essere risolto aumentando l’espressione e l’attività della fosfodiesterasi nelle 
successive fasi di sviluppo del sistema. 
 
 
 
 
 
7 
 
2.3 Abstract auf Deutsch 
HCN4-Kanäle steuern die Frequenz des Herzschlags. Sie werden durch negative Spannung aktiviert und 
durch cAMP moduliert. Kürzlich wurde entdeckt, dass auch zyklische Dinukleotide an eine zweite Stelle im 
C-Terminus des Kanals binden können. Dies wirkt dem Effekt von cAMP auf die Aktivierung des Kanals 
entgegen. Eine bakterielle Cyclase, die c-di-GMP als Reaktion auf Rotlicht synthetisiert, ermöglicht die 
Entwicklung eines optogenetischen Systems zur ferngesteuerten HCN4-Modulation und damit zur 
Steuerung des Herzrhythmus. 
Zwei Proteine wurden verwendet: eine konstitutiv aktive (Slr1143) und eine rotlichtregulierte (BphS) 
Cyclase. Da letztere eine gewisse Dunkelaktivität aufweist, wird eine Phosphodiesterase (YhjH) 
koexprimiert. Aufzeichnungen über die HCN4-Aktivität in HEK293T-Zellen zeigen, dass Slr1143 die 
Spannungsabhängigkeit von HCN4 beeinflusst; Slr1143 verschiebt die Aktivierungskurve des Kanals relativ 
zur Kontrolle in Richtung negativer Membranspannungen. 
Experimente mit BphS zeigen keinen Unterschied in der HCN4-Aktivität zwischen Zellen, die im Hellen oder 
Dunklen inkubiert wurden. Die kombinierte BphS-YhjH-Expression schien nicht in der Lage zu sein, die c-di-
GMP-Konzentration in einer lichtabhängigen Weise zu erhöhen. Um die Wirkung von Licht auf die c-di-
GMP-Produktion zu untersuchen, haben wir die zyklische Dinukleotid-Konzentration mit einem etablierten 
ELISA-Assay in HEK293T-Zellen und mit einer Immunfluoreszenzmethode quantifiziert. Letztere bestand in 
der Überwachung der Expression von Interferon-β in BphS-YhjH exprimierenden T-Zellen. Zyklische 
Dinukleotide können den STING-Pfad aktivieren, der die Synthese von Interferon-β verstärkt. Beide 
Methoden zeigten, dass sowohl Slr1143 als auch das BphS-YhjH-System zu einer Erhöhung des zellulären c-
di-GMP-Spiegels führen. Diese Aktivität war jedoch nicht durch Licht reguliert. Die Eliminierung von YhjH 
hatte keinen Einfluss auf das c-di-GMP-Level, was darauf hindeutet, dass die Phosphodiesterase nicht in der 
Lage ist, die Produktion von c-di-GMP im Dunklen zu unterbinden. Die Daten bestätigen die bisherigen 
Ergebnisse, dass c-di-GMP in der Lage ist, die HCN4-Aktivität zu modulieren. BphS ist aufgrund seiner hohen 
Dunkelaktivität noch nicht als optogenetisches Werkzeug geeignet. Um dieses Problem auf dem Weg zur 
Konstruktion eines funktionsfähigen optogenetischen Werkzeugs zu überwinden, muss die 
Expression/Aktivität der Phosphodiesterase erhöht werden. 
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3.1 Birth and development of a powerful technique 
Optogenetics is an innovative and powerful approach that combines methods of genetic and optical 
techniques to trigger or inhibit well defined events in specific cells of living tissues (Deisseroth, 2015). The 
principle of optogenetics is to remotely modulate cellular events of interest with light. The effective light 
stimulations can be applied in a very fast manner and further fine tuned by grading the power and/or the 
wavelengths of the stimulating light. The final light stimulation can then penetrate, with or without the help 
of specific light guides, deeply into the tissues. The modulation of cellular processes by light stimulation can 
be achieved by the expression of specific photo-regulated proteins in the target cells. An activation of these 
light sensitive proteins then leads, directly or indirectly, to the desired effects (Rost et al., 2017). 
The principle of optogenetics was introduced in 2015 by Boyden and colleagues as a tool for selectively 
controlling the activity of specific types of neurons (Deisseroth, 2011). The neural circuits are highly 
complex systems in which different types of neurons stimulate or inhibit each other. The great challenge 
for neurobiologists was to experimentally dissect these complex circuits and investigate the role of each 
class of neuron in the information processing (Boyden, 2011). Before the introduction of optogenetics 
important insights into the role of different neurons within a circuit could be provided by direct electrical 
stimulation of cells in intact brain tissue. The drawback of this method is that neurons belonging to a 
specific class are often sparsely embedded within the tissue (Fenno et al., 2011). An alternative approach 
for dissecting complex neuronal circuits was provided by pharmacological methods. This type of 
manipulation indeed offered a more precise way of targeting a specific cell type of interest with certain 
expression patterns. The drawback of this approach is that it requires the diffusion of chemical compounds 
to the site of action, which is in most cases too slow for manipulating the desired activity of neurons (Fenno 
et al., 2011). Scientists realized since the late seventies that to understand more deeply how the brain 
works they needed a method by which neurons of just one type could be manipulated, leaving the others 
unaffected (Crick, 1979). The ideal technique would employ a genetically encoded tool, which is selectively 
expressed in a defined class on neurons and which is able to affect excitability in response to a diffuse and 
fast stimulus. The first step in this direction was the intuition that light could be such a stimulus, fulfilling 
the need for speed, diffusion and simplicity of delivery. 
Before optogenetics was introduced, other researchers already had the idea of using light as a remote and 
non-invasive stimulus to elicit neuronal firing. Zemelman and colleagues conferred photo-sensitivity to 
hippocampal neurons by co-expressing in these cells the elements of the phototransduction machinery of 
Drosophila (Zemelman et al., 2002). In invertebrates, the stimulation of the photoreceptors activates a 
pathway that eventually causes cell depolarization via opening of cation channels. By expressing the 
phototransduction elements in hippocampal neurons, they were able to elicit the firing of action potentials 
in response to light irradiation. The light activated firing was obtained also in neurons treated with 
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inhibitors of glutamate receptors, proving that the observed action potentials were not provoked by 
excitatory synaptic inputs. However, the recordings of action potentials in these light-sensitive neurons 
indicated that there was a delay of 0.5÷34 seconds between the beginning of the irradiation and the 
appearance of the firing. The technique, although interesting, was not  providing the desired temporal 
precision. 
To achieve an activation of neural firing with a higher  temporal precision, the pioneers of optogenetics 
expressed in neurons an ion channel that is directly gated by light. This system does not require any 
signaling cascade or second messenger between light perception and membrane depolarization. The crucial  
channel, which provided these features, was channelrhodopsin-2 (ChR2), a light-activated ion channel from 
Chlamydomonas reinhardtii, first characterized by Nagel and colleagues in 2003 (Nagel et al., 2003). Before 
the publication of this seminal work it was already known that this channel uses retinal as a chromophore 
to sense light, and that the activity of the channel was involved in the generation of “photocurrents” in the 
algae when the latter are irradiated with blue light (Sineshchekov et al., 2002). When Nagel and colleagues 
characterized this protein, they clearly demonstrated that it was both a light sensor and an ion channel. 
They expressed the protein into Xenopus laevis oocytes supplied with all-trans retinal. In these oocytes they 
were able to measure a blue light-activated inward current that displayed a peak followed by a decay to a 
steady state level (Fig. 3.1 A). The channel turned out to be permeable for mono and divalent cations, while 
anions did not contribute in any way to the measured currents. The authors furthermore performed inside-
out patch clamp experiments: with this technique it is possible to measure currents flowing through a small 
piece (patch) of membrane that is isolated from the rest of the membrane and the cytoplasm. In this 
configuration channel gating cannot depend on potential regulators or signaling cascades from the 
cytoplasm. Using excised patches the authors confirmed that even after isolating the channel from the 
cytoplasm it was still able to elicit a light-activated current similar to that observed in whole-cell 
measurements (Fig. 3.1 B). With this work it was proven that ChR2 is cation channel, which is directly gated 
by blue light.  
 
Fig 3.1 Characterization of ChR2. (A) Currents recorded in Xenopus laevis oocytes expressing ChR2. When the voltage was clamped 
at -100 mV, blue light illumination elicited the activation of an inward cation currents. (B) Inside-out patch-clamp recordings of a 
patch of membrane from an oocyte expressing ChR2. (figures from Nagel et al., 2003). 
A B 
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Boyden and co-workers understood that this peculiar channel from an alga could be used to elicit action 
potentials in neurons in a light dependent manner (Boyden et al., 2005). The channel opens upon blue light 
illumination and is selective for cations. Because of the electrochemical gradient across the membrane of 
neurons, the opening of a cation channels will cause an inward flux of positive ions and hence a 
depolarization of the membrane potential. This in turn will trigger the generation of action potentials. For a 
proof of concept, Boyden and coworkers infected cultured rat neurons with lentiviruses containing a Chr2-
YFP fusion protein. In these cells they were able to measure blue light activated inward currents similar to 
those measured by Nagel one year before (Fig 3.2 A and B). Under continuous blue light irradiation they 
observed an appreciable depolarization of the membrane potentials and the rise of spiking activity. The 
latter appeared few milliseconds after the light stimulation began but the frequency decreased 
dramatically during the stimulation (Fig. 3.2 C). Given the rapid activation of Chr2 by light and the 
consequent depolarizing current, they also succeeded in eliciting single action potentials by short single 
blue light flashes. They found that a light flash of 15 ms was able to generate a complete action potential 
and that multiple light pulses separated by dark periods were able to generate high frequency firing in the 
neurons (Fig. 1.2 D). Thanks to such an incredible temporal precision, they were able not only to elicit 
neuronal firing but also to regulate the frequency of their spikes by modulating the light pulses frequency. 
The results of these experiments show that the concentration of retinal in neurons is evidently sufficient  
for a proper Chr2 function. Collectively this implied that this optogenetic tool is totally genetically encoded 
and does not  require to treat the cells with any exogenous compound. This is an important feature for an 
optogenetic tool, as its ability to response to light will not depend on the delivery of chemicals to cells. In 
the same period in which Boyden and colleague developed optogenetics, another research group 
engineered a light-activated channel called SPARK (Banghart et al., 2004). The shortcoming of this channel 
is that it needs to be supplied with an exogenous molecule that confers light dependence to the gating. The 
system developed by Boyden and colleagues is, on the contrary, intrinsically light regulated. 
In the past decade the optogenetics methods have been further developed and the technique has been 
enriched with new tools, some of which are present in nature and belonging to the opsin family (Mei and 
Zhang, 2012). An example of these proteins is the yellow light regulated chloride pump halorhodopsin from 
Natronomonas pharaonis (NpHR). This is a pump that is able to transport chloride ions across the 
membrane into the cytoplasm (Bamberg et al., 1993). The transfer of negative charges into an excitable 
cells should hyperpolarize the membrane potential, preventing the rise of action potentials. This is indeed 
what happened when NpHR was expressed into neurons: an illumination with yellow light led to a 
hyperpolarization of the membrane potential and an inhibition of firing (Fig. 1.3, Zhang et al., 2007). Action 
potentials were in this case induced by injecting positive currents into the cells. The ability of this 
stimulation to induce firing  promptly disappeared when the yellow light was turned on. 
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Fig 1.2 Expression of Chr2 in neuronal cells. (A) Currents recorded in cultured rat neurons expressing Chr2 when they were 
exposed to continuous blue light. (B) Multiple inward currents elicited by irradiating the cells with short light pulses. (C) Membrane 
potential in Chr2-expressing neurons: upon illumination with continuous light the frequency of the spikes decreases with time. (C) 
Short light pulses allowed to finely modulate the frequency of the action potentials: 15ms long pulses were the best to generate 
complete action potentials. In the four figures light pulses are indicated with bars. (Figures from Boyden et al., 2005).  
 
It was interesting to note that NpHR was able to counteract the effect of Chr2 when the two proteins were 
coexpressed in neurons. In this scenario the pump inhibited the firing caused by Chr2 upon irradiation with 
blue light. This inhibitory optogenetics tool NpHR was also expressed into moto-neurons of Caenorhabditis 
elegans. In this context the activation of the pump caused a complete inhibition of the animal’s swimming 
activity (Zhang et al., 2007).  
 
Fig 3.3 NphR is able to silence the neurons. (A) Membrane potential variation recorded in cultured rat neurons expressing NphR 
when they were exposed to continuous yellow light. (B) Action potential recorded in neurons expressing NphR: the 
hyperpolarization caused by the yellow light inhibited the neurons electrical activity. (Figures from Zhang et al., 2007). 
 
A B 
C D 
A B 
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Some other more recently developed optogenetic tools are proteins that cannot be found in nature; they 
are the product of protein engineering. These constructs are usually designed to confer light sensitivity to a 
protein responsible for the effect that one wants to control. For this purpose the photosensitive domain of 
a light regulated protein is in most of the cases fused with the protein of interest. In the past years, new 
synthetic proteins for optogenetic applications have been engineered using, as regulatory domain in these 
chimeras, the LOV2 domain of the plant phototropin 1 (Cosentino et al., 2015; Niopek et al., 2014; Pham et 
al., 2011; Strickland et al., 2008). This domain, which is part of a blue light sensor in plants, is composed by 
antiparallel β-strands that form an hydrophobic cavity (cage or core), in which the chromophore flavin 
mononucleotide is held uncovalently. The C terminus of the cage contains an amphipathic alpha helix called 
Jα, whose apolar side docks onto the core (Fig 1.4 A, Christie, 2007). Irradiation of the domain induces the 
formation of a covalent adduct between the C(4a) carbon of the flavin chromophore and a conserved 
cysteine residue within the LOV2 domain. The conformational rearrangements in the cage, that occur after 
the formation of the covalent bond, cause the disruption of the interaction between the cage and the Jα, 
which partially unfolds. This unfolding of the Jα results in an activation of the kinase domain of the 
phototropin, located at the end of the helix (Fig. 1.4 B, Christie, 2007). The LOV2 domain is therefore able 
to keep a catalytic domain blocked against its core and to “release” it in response to blue light. 
An elegant example for the construction of new optogenetics tools using the LOV2 domain, is the light 
gated potassium channel BLINK (Cosentino et al., 2015). Potassium channel opening drives the membrane 
voltage negative and hence terminates in this way action potentials and prevents firing in excitable cells 
(Hille, 2001). Such a light sensitive K+ channel could be very useful for optogenetics because opsin-based 
hyperpolarizing optogenetic tools have some shortcomings. First, these ion pumps are rather inefficient 
because they move only one ion per photocycle. Notably a channel conducts in contrast up to 108 ions per 
second. Moreover the pumps also create abnormal ion gradients in cell. For these reasons, the optogenetic 
community had been looking for a more efficient and genuine light-gated channel, which can be used to 
hyperpolarize cells. In 2015 Cosentino and co-workers constructed a light-gated potassium channel by 
fusing the LOV2 domain to a viral potassium channel called Kcv (Fig 1.4 C). This is a very small potassium 
channel composed by only the pore module of a K+ channel lacking any regulatory domain (Plugge et 
al.,2000). The design of this synthetic channel was inspired by the finding that channel proteins are often 
modular elements in which the pore, which conducts the ions, is connected with regulatory domains 
(Arrigoni et al., 2014). Conformational changes of the regulatory domain can be transmitted to the pore 
unit were they alter the flux of ions. This natural architecture of ion channels can be mimicked in synthetic 
proteins in which a channel pore unit is coupled in an intelligent manner with a foreign regulatory or sensor 
unit (Arrigoni et al., 2014, Difrancesco et al., 2015). The native fusion of the a viral potassium channel pore 
to the LOV2 domain resulted, after some optimization steps, in a potassium channel that could be 
reversibly gated by blue light (Fig. 1.4 D, Cosentino et al., 2015). 
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Optogenetic principles can also be used to regulate different types of cellular processes beyond the control 
of changes in the membrane voltage. An interesting example for such a system that does not involve ion 
currents, is presented in the work from the Di Ventura’s group (Niopek et al., 2014; Niopek et al., 2016; Di 
Ventura, 2016). They were able to control, precisely and reversibly, nuclear translocation of proteins in 
human cells. They used the LOV2 domain as photo-switch and added at the C terminus of the Jα a nuclear 
localization signal (NLS). The latter is concealed from the nuclear import machinery in the dark state but, in 
the light, the Jα helix unfolds and undocks from the AsLOV2 core domain, exposing the NLS to the 
cytoplasm (Fig 1.4 E). In this condition the NLS can be recognized and bound by the endogenous importins. 
They named this light-inducible nuclear localization signal LINuS. A construct made by Mcherry and LINuS 
(Fig 1.4 F) was expressed in different cell types. In cells expressing this construct it was possible to see that 
the mCherry fluorescence signal was present both in the nucleus and the cytoplasm in the dark. To reduce 
the background nuclear localization of LINus, they added also a nuclear export signal (NES). This new 
construct was, in the dark, dispersed in the cytoplasm but was not present in the nucleus. Upon 
illumination, they observed the occurrence of a mCherry signal in the nucleus, which indicated that the 
protein was being relocated there (Fig 1.4 G). With LINuS as an optogenetic tool they are now able to 
control cellular events that involve nuclear translocation of a protein or a set of proteins. Examples are 
mitotic entry or gene expression. In the next step they used the same principles behind LINuS to create a 
light dependent export signal called LEXY. 
With this brief overview, I want to show the principles optogenetics and the importance of this new 
technology in biological sciences. A number of recent reviews underscore the great impact on this new 
concept on progress in research in many fields (Rost et al., 2017; Boyle at al., 2018). To complete the 
picture I also described some examples of synthetic proteins, which were designed to expand the collection 
of neurophysiology tools or to achieve the modulation of new and different cellular events. 
Optogenetics is a dynamic and rapidly evolving field that can be enriched with new light-inducible proteins 
to control different phenomena. This PhD work was motivated by the idea to further expand the 
optogenetics toolbox. The particular goal was to create a system which allows a light-regulated gating of 
the HCN4 channel and, with this, a way to modulate the heart rate in an non invasive manner. The rationale 
behind this approach will be presented in the next chapter. 
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Fig 1.4 New synthetic LOV2-based proteins for optogenetics. (A) Structure of LOV2 domain of phototropin 1 (Christie, 2007). (B) 
The unfolding of the Jα helix leads to the activation of the effector domain of the phototropin 1 (Christie, 2007). (C) Schematic 
representation of BLINK1, a synthetic light-gated potassium channel in which the LOV2 domain is fused to the N terminus of the 
potassium channel Kcv (Cosentino et al., 2015). (D) I/V curves obtained from HEK293T cells expressing BLINK1 in the dark (black 
squares), after irradiation with blue light (blue dots) and after dark recovery (empty triangles) (Cosentino et al., 2015). (E) Cartoon 
representing how, upon light irradiation, the NSL is exposed to cytoplasm in LInuS (Niopek et al., 2014). (F) The fusion protein LINuS 
(Niopek et al., 2014). (G) Reversible nuclear migration of LINuS in response to blue light can be observed by monitoring the 
mCherry fluorescence (Niopek et al., 2014). 
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3.2 The HCN channel family and the role of HCN4 in sinoatrial node cells. 
Hyperpolarization-activated cyclic nucleotide gated channels (HCN1-4) are a family of ion channels, which 
are expressed both in the brain and in the heart. They are voltage dependent and open upon 
hyperpolarization of the plasma membrane; at depolarized voltages they are closed. In addition to a 
regulation by voltage, the activity of these channels is also modulated by the binding of the second 
messenger cAMP to a cytosolic binding domain (Biel et al., 2009). With respect to their regulation HCN 
channels share therefore characteristics with both voltage-gated and ligand-gated channels. A peculiar 
feature of HCN channels is that they are, different from K+ channels with the same architecture,  not strictly 
K+ selective. This means that not only K+ is permeating the pore, but also Na+  (Santoro and Tibbs, 1999; Biel 
et al., 2009). The selectivity ratio is approximately 3:1 meaning that for three K+ ions one Na+ is on average 
transported by these channels. 
The currents mediated by HCN channels were first discovered in the heart and immediately attracted the  
attention of physiologists because of their peculiarities in gating and selectivity. Different from all other 
channels known at this time, HCN channels were activated by hyperpolarization while all other voltage 
gated channels were activated by depolarization (Brown et al., 1979). As mentioned before the current 
carried by these channels was not selective for K+ alone but a mix of both K+ and Na+ (DiFrancesco et al., 
1986). For these reasons the current was named “funny” current (If) in the first place although now is often 
called Ih (Barbuti and DiFrancesco, 2008). Later, an hyperpolarization activated current, named Ih, was 
measured also in neurons (Pape, 1996) and the genes of the HCN isoforms began to be identified at the end 
of the nineties (Ludwig et al., 1998; Ludwig et al., 1999; Santoro et al., 1997; Santoro et al., 1998; Vaccari et 
al., 1999). 
Recently the structure of HCN1 was solved by high resolution cryoEM. Hence new information and possible 
explanations for the particular behavior of these channels are now available (Lee and MacKinnon, 2017). 
From the structural data it becomes evident that HCN channels share some features with voltage gated K+ 
channels (Kv). The channel is composed of four subunits and each of them presents three modules: the 
voltage sensor domain (VSD), the pore module and a cyclic nucleotide–binding domain (CNBD) (Fig. 3.5). 
The latter is connected to the pore module via the so-called C-linker region, which is protruding into the 
cytoplasm. The four subunits are organized to form a central pore surrounded by the four VSDs, as in Kv 
channels (Fig. 3.6; Lee and MacKinnon, 2017). 
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Fig. 3.5 HCN channel subunits. General structure of one HCN subunit (Robinson and Siegelbaum 2003). 
 
 
Fig. 3.6. Structure of an HCN channel. Spatial organization of the four subunits to form a functional HCN1 channel. HCN1 present a central pore 
surrounded by four VSDs. The C-linker and the CNB are in the cytoplasm underneath the pore (Lee and MacKinnon, 2017). 
 
Pore opening in HCN channels is regulated by the four VSDs, each of them composed of four 
transmembrane helices (S1-S4) as in channels of the Kv family. In the latter channels the S4 segment 
contains positively charged residues, known as gating charges. Their  position in the membrane is strongly 
affected by the polarity of the transmembrane electric field (Larrson et al., 1996; Börjesson et al., 2008; 
Bezanilla 2008). During depolarization, the S4 segment undergoes a combined movement of rotation, tilt 
and vertical translation toward the extracellular side of the membrane: this conformational change in the 
VSD controls the gating of the pore (Long et al., 2005; Blunk and Batulan, 2012). Interestingly, in HCN 
channels the voltage sensor has an S4 segment with positive charges as well. Early studies about S4 
movement were done using an HCN channel from sea urchin and suggested that the vertical translation of 
this segment was conserved in HCN channels (Männikko et al., 2002). However, later studies showed that 
for human HCN channels the mechanism seems to be more complicated (Vemana et al., 2004; Bell et al., 
2004; Gross et al., 2018). These studies pointed out that a lateral displacement of S4, rather than a vertical 
movement, seems to be of central importance in HCN voltage sensing, which may be modulated by a 
rearrangement of the TMDs surrounding the S4 domain (Bell et al., 2004; Gross et al., 2018) . Moreover, 
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the S4 segment in HCN channels is longer than that of Kv channels and it extends in the cytoplasm (Fig. 3.7 
A; Lee and MacKinnon, 2017). It has been proposed that this extraordinary length of the S4 helix allows an 
interaction between the C-linker and the so-called S4-S5 linker, which connects the S4 to the S5 helix (Lee 
and MacKinnon, 2017; Gross et al., 2018). This interaction, when the S4 helix is in the “depolarized 
position”, may stabilize the closed state of the pore and may be involved in cAMP effect on the voltage 
dependence. 
The voltage sensor is directly connected to the pore via the so-called S4-S5 linker, consisting of few amino 
acids (Lee and MacKinnon, 2017). The pore module is made of two transmembrane helices (S5 and S6) 
separated by the pore helix and the selectivity filter. It has already been mentioned that HCN channels 
allow the permeation of both K+ and Na+ with a permeability ratio PNa:PK of about 1:3 (Santoro and Tibbs, 
1999). Surprisingly, HCN channels contain the same essential amino acids that are required to form the K+ 
selectivity filter in highly selective K+ channels (Biel et al., 2009). The structure of the HCN1 obtained by Lee 
and MacKinnon in 2017 is now able to explain the low K+ selectivity of HCN channels. It  shows that the first 
two amino acids of the selectivity filter have a different orientation compared to that of canonical 
potassium channels (Lee and MacKinnon, 2017). As a consequence, the outer half of the selectivity filter 
appears to be dilated. In K+ selective channels this part of the filter contains two of the four binding sites 
that coordinates the entrance of K+ ions. The presence of four sites in selective K+ channels allows two 
K+ ions to bind simultaneously (Zhou et al., 2001). The outer part of the filter in HCN1 in contrast is much 
wider so that sites 1 and 2 are absent (Fig. 3.7 B). Lee and MacKinnon hypothesized that “a filter in which 
only a single ion can bind, even if the binding is thermodynamically favorable for K+ over Na+, will not 
exhibit strong kinetic selectivity because an entering Na+ ion, which will only reside very briefly, will rapidly 
exit to either side (i.e., it can permeate)” (Lee and MacKinnon, 2017). On the contrary, in K+ selective 
channels a multi-K+-ion occupancy in the filter can augment the probability of Na+ exiting from the same 
side that it entered. The latter is favored by a K+ ion hindering the transition into the other direction. Given 
the particular nature of this selectivity filter architecture in HCN1, channel opening at the resting 
membrane potentials of neurons or cardiomyocytes will result in an inward current, which depolarizes the 
membrane. This depolarization brings the voltage to the threshold for activation of an action potential. The 
importance of this depolarization is explained in details in the next paragraphs. 
As mentioned previously the pore is connected, at its C-terminal end, to the regulatory domain CNBD. This 
ligand binding domain includes α-helices (A, P, B, C, D and E) and a β-roll between the A and B helices 
(Zagotta et al., 2004; Lolicato et al., 2011; Saponaro et al., 2014; Lee and MacKinnon 2017). The latter also 
contains the so-called phosphate binding cassette, which forms the cAMP binding pocket. cAMP binding to 
this site causes major spatial reorientation of the helical components of the CNBD; in particular, the B and C 
helices move toward the core of the CNBD (Fig. 3.7 C, Saponaro et al., 2014; Lee and MacKinnon 2017). This 
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movement is propagated to the C-linker region, which connects the CNBD to the S6 helix of the pore (Gross 
et al. 2018). The final effect of cAMP binding is an acceleration of the activation kinetics of the channel 
concomitant with a positive shift of the voltage dependency of activation. As a consequence the channel 
opens, in the presence of high concentrations of this cyclic nucleotide, at less hyperpolarized voltages (Fig. 
3.7 D). Important to note here is that the binding of the cyclic nucleotide to the CNBD is not sufficient for 
channel opening. The primary stimulus for channel opening is provided by negative membrane voltage. 
Binding of the ligand to the CNBD is only modulating in an allosteric manner the effect of membrane 
voltage on the channel. Binding of cAMP to the CNBD is in this scenario effectively lowering the energy 
barrier for channel activation by negative voltage. 
When Lee and MacKinnon presented the structure of HCN1, they pointed out that the N-terminal part of 
the protein is organized in a 3-α-helical domain (called HCN domain). This domain forms a contact with 
both, the S4 helix of the same subunits and the CNBD of a neighbor subunit (Lee and MacKinnon, 2017). 
Since the HCN domain is in contact with both regulatory elements of the channel, e.g. the voltage sensor 
and the ligand binding domain,  it may have a key role in the dual regulation of HNC channel gating. 
 
 
Fig. 3.7 Unique features of HCN channels. (A) HCN channels display a gating behavior opposite of that observed in other voltage dependent K+ 
channels. This may be due to the length of the S4 segment: this helix is longer in HCN (blue) compared to that of Kv channels (orange) (Lee and 
MacKinnon, 2017). (B) Comparison between the structure of the selectivity filter in HCN1 and in KcsA, a well known and characterized potassium 
channel (Lee and MacKinnon, 2017). (C) The binding of cAMP to the CNB causes the conformational reorientation of the helical parts, that are 
evident when comparing the structures of the unbound (orange) and bound (violet) state (Saponaro et al., 2014). (D) cAMP effect on the voltage 
dependency of the channel: the opening is shifted to less negative voltages as shown in this illustration by Biel et al. (2009). 
A B 
C D 
20 
 
The present work focuses on one member of the HCN family namely the HCN4 isoform. This channel plays a 
key role in the generation and the regulation of the spontaneous electrical activity of the heart. HCN4 is 
indeed the HCN isoform, which is most highly expressed in the sinoatrial node (SAN), the natural 
pacemaker of the heart (Shi et al.,1998; Difrancesco 2010; Baruscotti et al.,2010). Therefore HCN4 provides  
the main contribution to the If current and in this way to the autonomous pace making of the SAN. SAN 
cells display a spontaneous and rythmic electrical activity, which means that they are able to fire 
continuously action potentials, without the requirement of any excitatory input from the nerves. The 
electrical signals generated in the SAN propagate through the whole heart causing the rhythmical 
contraction of the cardiac muscular tissue and, therefore, the beating of the heart. 
The spontaneous firing of the SAN is possible thanks to the peculiar characteristics of the HCN channels, 
which were described in the previous paragraphs: the opening at hyperpolarized voltages and the ability to 
conduct both Na+ and K+. The mechanism was first proposed in the seventies and eighties of the last 
century on the basis of several experimental observation (reviewed in DiFrancesco 2010). It was observed 
that an action potential depolarizes at its peak up to +30 mV before returning back to negative voltages 
(repolarization) by the opening of K+ channels. This repolarization phase causes the membrane voltage to 
hyperpolarize up to -60 mV, a voltage at which the HCN channels start to open. The opening of the HCN 
channels at negative voltages results, because of the electrochemical gradient existing across the 
membrane, in the depolarizing current If. As a consequence the membrane potential slowly depolarizes, a 
phenomenon known as slow diastolic depolarization (SDD). The SDD brings the voltage to the threshold for 
the subsequent action potential (Fig. 3.8). Thanks to the unique biophysical properties of HCN channels, the 
SAN cells are able to continuously generate firing: the last phase of an action potential triggers the 
mechanism that leads to the activation of another one. 
 
 
Fig. 3.8 Spontaneous generation of action potential in SAN cells. Membrane voltage recording of a SAN cell. The SDD brings the potential from 
about -60 mV to the threshold for the activation of a subsequent action potential (Baruscotti et al., 2010). 
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As previously mentioned, the voltage dependency of the channel is shifted to positive voltages following 
cAMP binding. The degree of the shift along the voltage axis is in this case a function of the cAMP 
concentration (DiFrancesco and Tortora, 1991). This mechanism allows a fine tuning of the If current by 
physiological changes in the concentration of this second messenger in the cytoplasm. As a result of this 
tuning of HCN4 activity in SAN cells, the timing and the duration of the SDD is modulated by the cAMP 
concentration. The latter, in SAN cells, increases and decreases after beta-adrenergic and cholinergic 
stimulation, respectively (Sicchitano et al., 2012). The adrenergic and muscarinic receptors are in this 
scenario the initiators of pathways, which eventually affect the concentration of cAMP and therefore the 
opening of HCN4 channels (Barbuti and DiFrancesco, 2008). An increase of the intracellular concentration, 
of cAMP as output of a signal cascade, will in this way augment opening of the channel already at less 
negative voltages. This in turn affects the activation of theSDD, causing a faster frequency of the firing (Di 
Francesco, 1993; Biel et al.,2009). Fig. 3.9 illustrates the dependency of heart rate on cAMP concentration. 
An elevation of cAMP concentration due to the presence of Isoprenaline, causes a decrease in the time 
interval between two action potentials resulting in an acceleration of the heart beat. The reverse occurs 
when the cAMP level decreases in response to Acetylcholine stimulation. Thanks to its dual gating 
regulation by hyperpolarization and ligand binding, the HCN4 channel not only has the ability to elicit 
spontaneous auto-rhythmic activity, but it is also the final effector of the mechanism that determinates the 
beating frequency. This is the reason why the If current is also often called “pacemaker current”. 
 
 
Fig. 3.9 Pacemaking regulation. The slope, and therefore the duration, of the SDD is influenced by opposite types of stimulation: in the present 
example treatment with 10 nM isoprenaline and 3nM acetylcholine (DiFrancesco, 1993). The steepness of the SDD is a reflection of the modulation 
on intracellular concentration of cAMP, which can influence the opening of the HCN channels. 
 
In 2014 Lolicato and colleagues discovered a new and unexpected property of the HCN4: the response of 
the channel to cAMP can be counteracted, in an isoform specific manner, by cyclic di-nucleotides (Lolicato 
et al., 2014). In the latter study the HCN4 channel was crystalized in complex with cGMP. This cyclic 
nucleotide is also known to bind like cAMP the CNBD and affect pace making in the heart. Surprisingly, by 
analyzing the crystal structure, Lolicato and co-workers found a second binding site for cGMP (Lolicato et al. 
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2014). This binding site in the C-linker was called C-linker poket (CLP). The CLP is located between the 
second and the third helices of the C-linker, a region important for the propagation of conformational 
changes between the CNBD and the pore (Fig.3.10 A) (Gross et al. 2018). Further scrutiny of the structural 
data suggested that the pocket might be wide enough to bind a molecule about twice the size of cGMP. For 
this reason and supported by docking studies, the authors of this study tested, whether c-di-GMP or other 
cyclic di-nucleotides could bind the CLP and affect channel opening. 
For this purpose, they measured HCN4 activity in patch clamp recordings in HEK293 cells in presence and 
absence of 100 uM c-di-GMP, c-di-AMP and cGAMP in the recording pipette. The electrophysiological assay 
revealed that the cyclic di-nucleotides had by itself no effect on the voltage dependency of the HCN4 
channel. However when the measurements were repeated in presence of saturating concentration of 
cAMP (delivered via pipette as well) they found that cyclic di-nucleotides completely reversed the positive 
shift of the HCN4 activation curve. Only when cAMP was added to the pipette solution alone they observed 
the expected right shift; a co-presence of cAMP and cyclic di-nucleotides completely suppressed the 
positive shift of cAMP (Fig. 3.10 B). Control experiments confirmed the view that this effect was due to the 
specific binding of cyclic di-nucleotides to the newly discovered binding site. Mutations of amino acids, 
which were presumably involved in the binding of cyclic di-nucleotides to the respective site, eliminated 
the effect of these molecules. To test whether this antagonistic action of cyclic di-nucleotides on cAMP 
regulation of the HCN4 channel could affect a key physiological function of the channel such as  
peacemaking, the authors recorded the membrane potential of SAN cardiomyocites. Consistent with the 
effect of cyclic di-nucleotides on the HCN4 activation curve, the presence of cyclic di-nucleotides (in this 
case cGAMP) in the recording pipette caused a decrease in the spontaneous firing rate of SAN cells (Fig. 
3.10 C). Binding to CLP seems to prevent β-adrenergic stimulation on the If current, mimicking the 
physiological effect of acetylcholine. Since the newly discovered CLP is located in a region of the channel 
that connects the CNBD and the pore it was hypothesized that ligand binding to the CLP may hamper the 
transmission of the conformational change from the CNBD to the pore.  
Cyclic di-nucleotides are small molecule commonly used as second messenger in bacteria. The only second 
messenger present in mammals is the cGAMP, which is synthesized only in cells of the immune system in 
response to  exogenous DNA in the cytoplasm. C-di-GMP is not present at all in mammals and, in particular, 
in humans. Therefore it is tempting to exploit this system in an orthogonal pathway for regulating HCN4. In 
this work I tried to establish a system with a light regulated di-guanylate cyclases from bacteria, which 
might be used as a tool for a remote control of HCN4 channel activity and hence heart rate. 
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Fig. 3.10 The HCN4 channel is regulated by cyclic di-nucleotides. (A) The CLP found by Lolicato and colleagues is located between the so-called 
elbow and shoulder of the C-linker domain in HCN4. (B) The graph are reports three activation curves which describe the dependency of the 
channel open probability and voltage. Activation curves were measured in different conditions: recording pipette filled with standard intracellular 
solution (black squares); intracellular solution + 15 uM cAMP (Blue circles); intracellular solution + 15 uM cAMP + 100 uM c-di-GMP (orange 
triangle). (C) Recordings of the membrane potential in SAN cells in absence (left) or presence (right) of 100 uM cGAMP in the recording pipette. The 
rate observed in each condition is reported in the small graph. Data from Lolicato et al., 2014. 
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3.3 A photo-regulated diguanylate cyclase. 
Cyclic di-nucleotides have emerged as important second messengers in bacteria, where these molecules 
regulate many important cellular processes in response to diverse extracellular cues (Fig. 3.11 A, Kalia et al., 
2013). Among them, c-di-GMP, a universal bacterial second messenger, was first described in 1987 by Ross 
and colleagues as a cofactor of cellulose synthase (Ross et al., 1987). In the subsequent years it occurred 
that c-di-GMP is an ubiquitous signaling molecule synthesized from two GTP and is involved in cellular 
processes such as biofilm formation, motility, virulence, the cell cycle, differentiation (Romling et al., 2013). 
The final intracellular concentration of c-di-GMP is determined by the antagonistic action of the diguanylate 
cyclase (DGC) and phosphodiesterase (PDE) enzymes, which are responsible for the synthesis and the 
breakdown of this second messenger (Romling and Galperin, 2017). There are two types of enzymatic 
domains that display DGC or PDE activity, respectively: the GGDEF domain and the EAL domain (Fig. 3.11 B; 
Jenal et al., 2017; D’Argenio and Miller, 2004). The GGDEF and EAL domains are often found on the same 
polypeptide chain as parts of multi-domain proteins: about one third of all GGDEF domains and two thirds 
of all EAL domains are found in the same proteins (as reviewed in Romling et al., 2013). Most of these 
proteins containing a GGDEF-EAL tandem are not bifunctional and have therefore either DGC or PDE 
activity. In this type of proteins one of the two domains is not functional and has a different function, like in 
the CC3396 from Caulobacter crescentus (Christen et al., 2005). In this protein the GGDEF domain has no 
cyclase activity but instead binds GTP and in response activates the EAL domain. 
 
 
Fig. 3.11 Cyclic di-nucleotides are bacterial second messengers. (A) c-di-GMP and c-di-AMP are involved in many cellular pathways that modulate 
important cellular events like translation, biofilm formation, growth etc. (Kalia et al., 2013). (B) The cellular concentration of c-di-GMP is regulated 
by the antagonist action of GGDEF and EAL domains (Jenal et al., 2017). 
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One GGDEF-EAL domain tandem has been found also in a bacterial phytochrome, where it acts as the 
effector domain of the light sensitive protein (Tarutina et al., 2006). Bacterial phytochromes are a family of 
homodimeric photo-receptors that use biliverdin as a chromophore. Each subunit consists of a “photo-
switch” module and an output “effector” domain, that is typically a histidine kinase (Rockwell and Lagarias, 
2010). The photo-switch module is composed of three conserved domains: the PAS (Per-ARNT-Sim 
repeats), the GAF (cGMP phosphodiesterase/adenylate cyclase/FhlA transcriptional activator), and the PHY 
(phytochrome-specific) domains (Aldridge and Forest, 2011). The biliverdin is located in the chromophore-
binding pocket of the GAF domain and it forms a thioether bond with a conserved Cys in the neighboring 
PAS domain (Wagner et al., 2005). A scheme of the domain organization of each monomer is reported in 
Fig. 3.12 A. The C-terminal helix of the GAS domain is continuous with the first helix of the PHY domain, so a 
single long helix runs the length of the photosensory core and the PAS, GAF, and PHY domains are arrayed 
along it (Aldridge and Forest, 2011, Piatkevich et al., 2013, Takala et al., 2014). The PHY domain has a 49 
amino acids-long extension, called tongue, that reaches and contacts the cromophore-binding poket in the 
GAF domain (Takala et al., 2014). In the dark the BV is the cis form, that absorbs light at 670-700 nm; when 
irradiated with red light in this range of wavelengths, it converts into the trans form (Fig. 3.12 B, Piatkevich 
et al., 2013). 
In 2014 Takala and co-workers solved the structure of a bacterial phytochrome from Deinococcus 
radiodurans in the resting and activated states (Fig. 3.12 C, Takala et al., 2014). They observed that in the 
dark the monomers are fairly close to each other, while in the activated state the dimer adopts an open Y-
like shape of the PHY domains, which move apart by circa 3nm. They also found out that the transition of 
biliverdin into the trans form has an effect on the folding of the tongue, which changes its secondary 
structure from a β-sheet to an α-helix. As a result, the tongue is shortened and the distance between the 
GAF and PHY domain is reduced. As a consequence of this, the dimer opens up between the PHY domains. 
          
          
Fig. 3.12 Bacterial phytochrome photosensors. (A) Schematic representation of a bacterial phytochrome monomer with its domains. (B) Photo-
cycle of the biliverdin (Piatkevich et al., 2013). The chromophore in the cis form (also called Pr) has the absorption peak at 690 nm, while the trans 
form (Pfr) absorbs light at 750 nm. Irradiation with red light at 750 nm causes a fast recovery to the cis form. (C) Structure of a phytochrome from 
Deinococcus radiodurans; the tongue is colored in green (Takala et al., 2014). 
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As mentioned above, in 2006 Tarutina and colleagues discovered that a phytochrome in Rhodobacter 
sphaeroides, named BphG1, has a GGDEF-EAL tandem as output domains (Tarutina et al., 2006). This 
phytochrome has a canonical PAS-GAF-PHY photo-switch, that is connected to GGDEF and EAL domains 
(Fig. 3.13 A). To understand  the function of this unusual phytochrome, they added a His tag to the C 
terminus for purification and performed in vitro biochemical characterization after over-expressing the 
protein in E. coli. The E. coli strain they used for this purification expressed also heme oxigenase and 
therefore synthesized biliverdin as well. When they purified the protein, they observed a small amount of 
monomer, a presumed tetramer and other bigger oligomers. They found out that the whole protein BphG1 
had the typical photochemical properties of bacterial phytochromes: it was binding biliverdin and displayed 
absorption-emission peaks of these photoreceptors. This protein exhibited PDE activity but, surprisingly for 
a phytochrome, this activity was not light regulated (Fig. 3.13 A). They noticed that, together with BphG1, 
another small protein was co-purified. This small protein turned out to be a dimer of EAL domains, which 
had PDE activity as well (Fig. 3.13 B). They concluded that BphG could undergo a partial cleavage in E. coli 
and so they decided to characterize the remainder of the protein, i.e the PAS-GAF-PHY-GGDEF. Since the 
His tag was at the C terminus of the EAL domain, to purify this fragment they added a C-terminal tag to it. 
When they tested the enzymatic activity of this fragment they discovered that it worked as a light regulated 
diguanylate cyclase (Fig. 3.13 B). With these experiments Tarutina and colleagues showed that not only 
kinases but also other functional domains, can serve as output modules for phytochromes and that BphG1 
is a bifunctional protein with both c-di-GMP synthesis and hydrolysis function. Moreover, when BphG1 
undergoes partial cleavage, the truncated protein (that they began to call BphG) is able to synthesize the 
cyclic di-nucleotide in a light dependent manner.  
 
 
Fig.3.13 The BphG1 phytochrome. (A) The BphG1 protein is a bacterial phytochrome, with the typical photo-switch module, to which are connected 
a GGDEF domain and an EAL domain. The entire protein showed a light-independent PDE activity. (B) BphG1 undergoes cleavage to obtain two 
distinct proteins: EAL dimmers with PDE activity and a light-regulated DGC. (modified from Tarutina et al., 2006: colors have been changed to match 
those used in subsequent publications from the same group). 
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Some years later, the same group had the idea to use BphG for developing an optogentic tool, which is able 
to synthesize the second messenger c-di-GMP in a light dependent manner (Ryu et al., 2014). They 
monitored the production of c-di-GMP in vivo in E. Coli cells and found that the activity of the protein was 
very poor. The intracellular concentration of the second messenger was indeed incompatible with the 
activation of many c-di-GMP dependent processes. To improve the cyclase activity, they substituted the 
GGDEF domain of BphG with the GGDEF domain of a more active DGC from Synechocystis sp. called 
Slr1143: this Chimeric protein was called BphS1. Upon irradiation with red light, the BphS1 construct 
showed a circa 2.5-fold higher DGC activity compared to BphG. To further improve the cyclase activity of 
the chimera, they introduced a mutation in the conserved RXXD sequence motif located in the GGDEF 
domain of Slr1143. This motif is involved in a feedback inhibition mechanism of DGC activity. They 
introduced the mutation R587A (R250 of Slr1143) and eliminated the feedback inhibition system. A 
schematic representation of this protein assemble is reported in Fig. 3.14 A. The mutated construct (named 
BphS) turned out to have a DGC activity in the light that was circa 2.2-fold higher than that of BphS1 
and   5.5-fold higher compared to the original BphG. This modification hence resulted in an improvement of 
the DGC activity but, at the same time, caused also an unwanted increase in the dark activity of the protein. 
To circumvent this problem they co-expressed a constitutive PDE, which should maintain low levels of c-di-
GMP in the dark: YhjH (Fig. 3.14 B). 
The expression of YhjH needed to be adjusted to achieve degradation of the cyclic di-nucleotide in the dark 
without affecting (or affecting only minimally) the c-di-GMP synthesis in the light. To do this, they prepared 
different plasmids in which they inserted, upstream of YhjH, different ribosome binding sites (RBSs). They 
expressed the plasmid in E. coli cells and checked their motility. It was indeed known that c-di-GMP can 
bind a specific receptor that hampers the activity of the flagellum rotor. With this functional assay they 
were able to select the RBS, which offers the biggest difference in motility between light and dark (Fig. 3.14 
C). To further verify that the co-expression of BphS and YhjH can be used to photo-modulate cellular 
phenomena, they tested the ability of the system to activate a c-di-GMP-dependent expression system. 
They were able to obtain a light-dependent expression of lacZ, monitored with the color of the colonies.  
In further experiments the combined BphS-YhjH system could be used to increase the intracellular 
concentration of c-di-GMP in response to far red light and therefore to photo-modulate pathways activated 
by this second messenger. The construct has two important features. 1. It responds to red light e.g. a light  
that is able to penetrate tissues more deeply than blue or yellow light. 2. As mentioned in previous 
paragraphs, cyclic di-nucleotides are second messengers in bacteria, not in mammals. In humans, cGAMP 
can be found only in cells of the immune system under certain conditions, i.e. activation of the immune 
response, while c-di-GMP is totally absent in human cells. Since the bacterial and human system are 
orthogonal the c-di-GMP concentration in human cells can be manipulated without altering other 
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physiological signaling pathways, i.e. cascades which are activated by endogenous mammalian second 
messengers like cAMP. One target for the light-dependently produced c-di-GMP could be the HCN4 
channel, as it can be directly regulated by cyclic di-nucleotides. The aim of this work was to examine the 
possibility of using the bacterial cyclases described in the previous paragraph to photo-modulate channel 
gating of HCN4 and as a result the pacemaker current If in the sinoadrinal node. 
 
              
 
Fig 3.14 The synthetic BphS construct. (A) Construction of the Chimeric protein BphS  by fusing BphG and Slr1143. (B) The dual regulation of c-di-
GMP levels by BphS and YhjH. (C) Light regulation of c-di-GMP production reflects on the different motility in light and dark of bacterial cells 
expressing BphS and YhjH. The numbers indicates the different RBSs used. V indicates cells transformed with an empty vector. 
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3.4 Aim of the thesis 
The current progress in optogenetics underscores that the regulation of cellular events with light is very 
useful for research and applications in many areas of biology. This has stimulated the development of new 
optogenetic tools in the past years. With the present project we wanted to examine the possibility of 
designing a potential new optogenetic tool for a remote regulation of the HCN4 channel by light. This 
channel is crucially involved in the generation of the spontaneous electrical activity in the pacemaker cells 
of the sinus node and its activity determines the frequency of the heart beat. Like in the case of all HCN 
channels  also the gating of HCN4 is dually controlled by voltage and cAMP. The channel is activated by 
hyperpolarization and this voltage dependence is further modulated by cAMP. This second messenger 
binds the C-terminal domain of the channel in the cytoplasm, causing a positive shift in the channel voltage 
dependency. Upon binding of cAMP, the channel opens at less depolarized voltages as the binding of the 
cyclic nucleotide stabilizes the open state of the pore. The consequence of this cAMP mediated alosteric 
regulation of HCN4 channels, in the sinol adrial node, is a fine tuning of the beating frequency of the heart. 
It has been demonstrated that also cyclic di-nucleotides can bind the HCN4 channel, in an isoform specific 
manner, in a binding side upstream of the cAMP binding site. The effect of cyclic di-nucleotide binding to 
HCN4 is to counteract the effect of cAMP on the channel voltage dependence. The present project is 
inspired by the idea that the gating of HCN4 channels and consequently the frequency of heart beat can be 
influenced via a modulation of  cyclic di-nucleotides concentration in the sinus node . 
Cyclic di-nucleotides are ubiquitous second messengers in bacteria, where they regulate many different 
pathways. Among the cyclic di-nucleotides, c-di-GMP is completely absent in human cells. This implies that 
the synthesis and degradation of this molecule, by specific cyclases and phosphodiesterases, should not 
affect physiological pathways of human cells, in which cAMP or cGMP are used as second messengers. The 
idea of creating a light regulated system is based on the finding of a bacterial phytochrome, which catalyses 
the synthesis of c-di-GMP in a far red light dependent manner. It is important to mention that such a red 
light based optogenetic tool would favor applications over those triggered by blue light, since the former is 
able to penetrate tissues more deeply. 
Given the present state of the art, we decided to test  if it is possible to regulate the gating of HCN4 channel 
by using bacterial di-guanylate cyclases. For this purpose we co-expressed these enzymes in human cells 
together with HCN4 and tested if they were able to produce sufficient c-di-GMP in a light depednent 
manner for affecting the voltage dependence of the channel. In the case that the light-activated enzyme is 
able to generate an appreciable amount of  c-di-GMP, it should counteract the effect of cAMP on channel 
gating. By interfering with the cAMP dependent modulation of the funny current, this tool could be suitable 
to achieve a remote regulation of the heart rate.  
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4.1 A bacterial cyclase can modulate the voltage dependency of HCN4 channels 
I reasoned that the best strategy for the construction of a light-regulated modulation of HCN4 channel 
activity would be to start with the constitutively active diguanylate cyclase Slr1143 from the 
cyanobacterium Synechocystis sp. This protein was extensively described in the Introduction. The GGDEF 
domain of this protein is identical to the catalytic part of the light-activated construct BphS (Ryu and 
Gomelsky, 2014). By expressing Slr1143 in HEK293T cells and measuring HCN4 channel activity, I wanted to 
learn whether this protein is able to synthesize enough c-di-GMP to affect the voltage dependency of HCN4 
channels. These experiments should also provide information on the time which is required between 
transfection and the first measurable effect of c-di-GMP on HCN4 channel gating. The Slr1143 DNA for 
these experiements was provided by the laboratory of prof. Gomelsky. The gene was inserted in a pCAG 
expression vector that included a GFP tag (PCAG-GFP; PSV40-Slr1143). As mentioned in Matherials and 
Methods, for this work it was used rabbit HCN4 DNA (RbHCN4) that was included into a pCI vector (PCMV-
RbHCN4). From now on I will refer to this channel and its DNA simply as HCN4. GFP DNA was required to 
monitor the expression of the channel in control cells, given the lack of fluorescent tag in the pCI vector. 
The GFP gene was contained in a pMAX plasmid (PCMV-GFP). Both these two plasmids had been previously 
proved to be suitable for transfection and expression of GFP and HCN4 in HEK293T cells. The HEK293T cells 
were then transfected, as described in Materials and Methods, with 1 µg of HCN4 + 1µg of GFP (as control) 
and 1 µg of HCN4 + 1 µg of Slr1143.  
After 20 hours the activity of the heterologously expressed HCN4 channel was monitored by patch-clamp 
measurements in the whole-cell mode. Voltage-clamp protocols were applied and the corresponding 
currents were recorded as detailed in Materials and Methods. In the last step of each clamp cycle, the 
voltage was clamped to -40 mV. This step elicits the typical tail currents of HCN4 channels with a distinctive 
kinetics (Fig. 4.1 A). The tail currents, which are recorded immediately after a test pulse (second segment of 
a cycle), are a measure for the open probabaility of the channel at the test pulses. A plot of the tail currents 
as a function of the preceding test pulse can be used for an analysis of the voltage dependency of this 
channel. The amplitude of a tail current depends, indeed, on the number of channels that are open when 
the current reaches its plateau during the second phase of each cycle. In the latter, the voltage increases of 
+15 mV in each cycle and it is impossible to understand if the correspondent increases in current 
amplitudes are due to higher channel opening or just to the increased driving force. Since tail currents are 
all recorded at the same voltage but strongly depend on the voltages applied in the second segments of the 
protocol, they offer a better possibility to describe the voltage dependency. 
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Normalized tail current amplitudes were plotted as a function of the preceding test voltage. The sigmoidal 
transition of the closed channel at positive voltages to the open channel at negative voltages can be fitted 
with the Boltzman equation (Equation 1): 
             
            
    
     
  
     
where A1 is the maximal tail current amplitude, A2 is the minimum tail current value, x is the test pulse 
voltage, x0 is the half-activation voltage (V1/2) and dx is the slope factor. In this way it is possible to describe 
the relationship between channel opening and voltage (Fig. 4.1 C). 
Fig. 4.1 A shows an example for a measurement of HCN4 in a HEK293T cell under control condition, i.e. 
without co-expression of Slr1143. The cell exhibited the typical currents of this inward rectifying channel, in 
which hyperpolarizing voltages elicit a slow activating inward current. The kinetics of activation of HCN4, as 
in this case, is typically accelerated the more negative is the imposed the voltage. The steady state I/V 
relation of this recording showed that the channel is closed at positive voltages and only opens at voltages 
more negative than approximately -70 mV (Fig. 4.1 B). The tail currents are shown in Fig. 4.1 A and data for 
the activation curve were collected in the region marked by the red dashed lines. A plot of the normalized 
tail currents as a function of the test voltages exhibited the typical shape of the activation curve of this 
inward rectifier. It could be well fitted with the Boltzmann function yielding, in the present example, a value 
for V1/2 of -110 ± 0.7 mV (Fig. 4.1 C). The slope factors and other parameters for this and the rest of the 
figures are reported in Additional Information. The same measurements were repeated with 12 other 
control cells giving a mean half-activation voltage of -107.7 ± 1.6 mV (Fig. 4.2). HCN channels are known to 
display an high variability in the V 1/2 values: for the same channel different kinetics and V1/2 have been 
found by different laboratories (Biel et al., 2016; Biel et al., 2009). For this reason, every set of experiments 
includes control measurements; when changes in the V1/2 are shown, they always refer to the actual 
controls from the same set of experiments. 
The same measurements were repeated with cells co-expressing HCN4 and Slr1143. Fig. 4.1 A shows a 
representative recording from such a HEK293T cell. Scrutiny of the current responses showed that the 
currents were overall similar to those in control cells. But a closer inspection of the dynamics of activation 
indicated that co-expression of Slr1143 caused a slight slowdown of channel activation. The steady state I/V 
curve showed indeed that the channel began to open at more negative voltages compared to the controls: 
-90 mV in the reported example (Fig. 4.1 B). A plot of the tail currents indicated that the activation curve of 
the HCN4 channel is negatively shifted in the cell, which co-expresses the Slr1143 protein. In the present 
example the fit of the data with the Boltzmann function showed a 8 mV left shift compared to the control 
cells (Fig.4.1 C). 
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Figure 4.1 Co-expression of Slr1143 and HCN4 in HEK293T cells. (A) Exemplary current traces obtained by application of voltage protocols in control 
and Slr1143-expressing cells. Tail currents recorded at -40 mV of each current family are enlarged and reported on the right for each measurement. 
Amplitude values of the tail currents were taken in the region marked by the red dashed lines. (B) I/V curves from the measurements showed in (A), 
obtained by plotting the steady state current amplitudes as a function of the voltage. (C) Normalized tail current amplitudes plotted as a function of 
the preceding test voltage. Black dots: HCN4; Blue dots: HCN4 + Slr1143. Data points were fitted with the Boltzmann equation (equation 1). Color 
code for the fitting is the same used for the data points. 
The same experiments were repeated in 25 other cells where it turned out that the V1/2 values could be 
separated in two populations (Fig. 4.2). In 50% of the cells the V1/2 value was identical to the control. In the 
other 50% of the cells co-trasfected with HCN4 and Slr1143 (N=13) the V1/2 was -114.8 ± 0.9 mV. The 
comparison with control cells suggested that this negative shift, of about 7 mV, is related to the effect of 
the c-di-GMP on the endogenous cAMP binding to the CNBD. This result differed from what had been 
A 
B C 
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observed by Lolicato and colleagues, which didn’t see any effect of the c-di-GMP on the binding of basal 
level of cAMP to the  CNBD (Lolicato et al., 2014). 
To test the hypothesis that the synthesis of c-di-GMP affects the regulation of HCN4 by cAMP, the 
experiments in Fig. 4.1 were repeated by adding cAMP to the intracellualr solution (i.e. the pipette 
solution) at saturating concentration (15 µM). An analysis of the V1/2 values  from control cells showed that 
the presence of cAMP caused the expected right shift of the HCN4 activation curve (Fig. 4.2). The average 
V1/2 of control cells was -93.5 ± 2 mV (N=4). This value is similar to the cAMP induced shift of the activation 
curve in other studies and supports the robustness of the measurements. In cells co-transfected with HCN4 
+ Slr1143 the average V1/2 value was -95 ± 0.7 mV (N=6). The results of these experiments suggested that 
the enzyme was not synthesizing enough c-diGMP to counteract the effect of saturating concentrations of 
cAMP of the channel gating. 
 
Fig. 4.2 V1/2 values of control and Slr1143-expressing cells. Mean ± S.E. of the V1/2 values of HEK293T cells expressing HCN4 or co-expressing HCN4 + 
Slr1143 in presence or absence of cAMP in the recording pipette. Black circle: HCN4 (N=13); Blue circle: HCN4 + Slr1143, shifted (N=13); Blue 
trangle: HCN4 + Slr1143, not shifted (N=12); Empty Black circle: HCN4 + 15uM cAMP (N=4); Empty blue circle: HCN4 + Slr1143 + 15uM cAMP (N=6). 
 
The negative shift of the activation curve observed in cells expressing Slr1143 suggested that the c-di-GMP 
synthesized by Slr1143, could be potentially able to modulate the voltage dependency of HCN4. One 
mechanism by which it might do this is by interfering with the endogenous cAMP, which is present in the 
cells and affects channel gating. The fact that the expression of Slr1143 was however not able to counteract 
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saturating concentrations of cAMP, which were delivered via the pipette, might indicate that the enzyme 
was not synthesizing enough c-di-GMP to reverse the positive shift induced by this channel regulator when 
the concentration of the latter increased. This conclusion was consistent with the observation that the 
negative shift of the activation curve was only observed in 50% of the cells expressing Slr1143. It is 
reasonable to assume that the level of c-di-GMP synthesis was so low that it was only able to counteract 
the effect of the basal levels of cAMP on channel gating. In the light of these data we speculated that the 
activity of the Slr1143 enzyme was not as strong as it was expected to be. 
An idea for improving the performance of Slr1143 came from the literature. When Ryu and Gomelsky 
developed BphS, they created a chimera by substituting the cyclase domain of the phytochrome BphG with 
Slr1143 (Ryu and Gomelsky, 2014). Although the first results were encouraging, they needed to further 
improve the c-di-GMP synthesis by introducing in Slr1143 a mutation known to augment the catalytic 
activity of the GGDEF domain. For this purpose they mutated the arginine in position 250 (587 in the whole 
BphS protein) into an alanine. Inspired by these data I decided to insert in Slr1143 the R250A mutation and, 
moreover, to move it under a CAG promoter. This operation should increase both the expression and the 
activity of the protein. I decided to move the construct in a plasmid that contained, in this order: a CAG 
promoter, the multiple cloning site and an IRES sequence followed by a TdTomato (PCAG-IRES-Tdtomato) 
This pCAG plasmid was already available in the lab and successfully used for previous cloning by colleagues: 
for this reason was chosen to perform this cloning. 
The mutated gene was transferred into the new plasmid with an enzyme-free cloning technique called 
AQUA cloning (detailed description in Materials and Methods). This method requires the preparation of an 
insert with flanking regions of homology to a linearized expression vector. The insert and the linearized 
plasmid should then be transformed into competent E.coli cells, which will integrate the insert in the 
plasmid via homologous recombination (Beyer at al., 2015). The Slr1143 R250A insert was prepared by 
overlapping-PCR in order to insert the mutation and the flanking sequences. The desired PCR product was 
gel-purified while the PCAG-IRES-Tdtomato plasmid was linearized by digestion with a restriction enzyme and 
gel-purified as well. The insert and the linearized plasmid were then used to perform an AQUA cloning, 
after which colonies were obtained and subsequently screened by colony-PCR. A scheme of the procedure 
is reported in Fig. 4.3.  
The new plasmid was tranfected into HEK293T cells using the same amount of DNA employed in the 
previous experiments: 1 µg HCN4 + 1 µg Slr1143 R250A. After 20 hours, an unexpected effect was 
observed: the cells were all dead and detached from the bottom of the petri. I reasoned that the 
combination of the mutation and the new promoter were causing an over-expression of the protein and 
therefore an excess of c-di-GMP in the cytoplasm. This high concentration of the signaling molecule might 
have been the cause of cell death. To overcome this problem, I decided to try different experimental 
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conditions in which I varied the amount of transfected DNA and the after-trasfection time. By a fine tuning 
of these parameters, I should find the best way to express Sl1134 R250A in HEK2393T cells without killing 
them. 
 
Fig. 4.3. Schematic representation of the cloning procedure. By overlapping-PCR the mutation and the flanking sequences required for AQUA 
cloning were inserted. The insert was mixed with the linearized expression vector and the DNA mixture was transformed into competent cells. 
 
For the first set of experiments, HEK293T cells were transfected with only 0.5 µg of Slr1143RA + 1 µg of 
HCN4 and the time between the transfection and the measurements was reduced to 12 hours. The cells 
were alive and they looked morphologically good. However, only in few cells per day it was possible to 
measure currents with the amplitude and the typical features of HCN4 currents (Fig 4.5 A). Most of the cells 
showed currents with very low amplitudes, atypical activation kinetics and poor tail currents that were 
impossible to analyze. Fig. 4.4 shows a representative example of these measurements. 
 
 
 
Fig. 4.4 12 hours are not enough for a good expression of both the HCN4 channel and the construct. Exemplary current traces from cells 
expressing 0.5 µg of Slr1143RA + 1 µg of HCN4 recorded 12 hours after transfection. 
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I concluded that 12 hours were not enough to obtain a good expression of both the channel and the 
enzyme (Fig. 4.5 A). Nevertheless, these experiments showed that the mutagenesis and the cloning were 
affecting and presumably improving the system. In the days in which I obtained a reasonable channel 
expression, I was able to observe a negative shift of the V1/2 in 80% of the cells co-transfected with Slr1143 
R250A and HCN4. The average V1/2 of cells which co-expressed the channel and the mutated enzyme was  -
108.1 ± 1.36 mV (N=16). Control cells without Slr1143 measured in those days had a V1/2 value of -102.0 ± 
1.39 mV (N=14) (Fig. 4.5 C). The results of these experiments suggested that modifications in the protein 
and in the expression procedure, which should improve the synthesis and the activity of the contruct, are 
indeed effective: they improved the number of responsive cells.  
 
 
 
Fig. 4.5 Determining the proper conditions for expressing the mutated enzyme. (A) and (B) Estimation of the expression of HCN4 in HEK293T cells. 
Transfected cells were measured after 12 (A) or 18 (B) hours after transfection. For each experiments are reported the percentages of cells with the 
following features: high current intensity, clear HCN4 kinetics, presence of tail currents with closure kinetics. Black: HCN4 control cells; Blue: HCN4 + 
Slr1143 R250A co-transfected cells. C) Avarage V1/2 values ± SE of cells in which HCN4 currents could be recorded in the expreiments reported in (A). 
Black dots: HCN4 control cells (N=14); Blue dots: HCN4 + Slr1143 R250A co-transfected cells (N=16). (D) Avarage V1/2 values ± SE of cells in which 
HCN4 currents could be recorded in the expreiments reported in (B). Same color code as in (C), N=9 for both control and co-transfection. 
 
 
A 
C 
B 
D 
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To achieve an even better compromise between the amount of DNA to be transfected, the time after 
transfection and the channel expression, new experiments were performed. HEK293T cells were 
transfected again with 0.5 µg of Slr1143 R250A + 1 µg of HCN4 but the time between the transfection and 
the measurements was increased to 18 hours. In this way cells with a good expression of both HCN4 and 
Slr1143 R250A could be obtained (Fig.4.5 B). Measurements of HCN4 currents in these cells showed that it 
was possible to see again an effect of the c-di-GMP on the V1/2 in 80% of the co-transfected cells (Fig. 4.5 
D). The V1/2 value of the latter cells was -106.7 mV ± 0.5 mV (N=9). This value is again more negative than 
that of  control cells, which were measured in parallel (V1/2= -100.3 mV ± 0.9 mV (N=9)). 
In the next step we tested whether the endogenously synthesized cyclic di-nucleotide is now sufficient to 
counteract the effect of saturating concentrations of cAMP. The results of these experiments showed that 
cAMP at 10 uM in the pipette solution was able to cause a positive shift the activation curve of the control 
cells as expected (Fig 4.6 B). Measurements of HCN4 activity in cells co-expressing Slr1143 R250A exhibit a 
surprising response to cAMP. Fig. 4.6 B shows that cAMP shifted the activation curve of HCN4 to the same 
value irrespective of whether Slr1143 R250A was expressed or not. With cAMP the average V1/2 values was 
- 90.7 ± 1.3 mV (N=6) in control cells and -91.4 ± 1.5 mV (N=5) in cells transfected with the mutated enzyme 
(Fig 4.6 C). 
The effect of cAMP on channel opening could be noticed also in the current recordings (Fig 4.6 A), where it 
was possible to observe an acceleration of the current kinetics when the channel regulator was delivered in 
the cytoplasm. The cAMP-induced acceleration of the kinetics can be observed in both control and cells 
expressing Slr1143 R250A. The acceleration of the kinetics can be described with the T1/2 value, that is the 
time it takes a current to reach half of its full activation (plateau). To describe quantitatively that the effect 
of cAMP is the same in the two conditions, the T1/2 values for the currents elicited at -135 mV can be 
considered. For the current traces reported in Fig. 4.6 a, when no cAMP was present in the recording 
pipette, the T1/2 values for the control and the co-transfected cell were 678 and 828 respectively. For the 
current traces in which cAMP was present in the pipette the values were 542 for control cell and 549. 
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Figure 4.6 effect of cAMP in cells co-expressing Slr1143 R250A and HCN4. (A) Exemplary current traces obtained by application of voltage protocols 
in control and Slr1143-expressing cells. Tail currents (recorded at -40 mV) of each current family are enlarged and reported on the right for each 
measurement. (B) Normalized tail current amplitudes plotted as a function of the preceding test voltage. Black dots: HCN4; Blue dots: HCN4 + 
Slr1143 R250A; empty black dots: HCN4 + 10 uM cAMP; empty blue dots: HCN4 + Slr1143 R250A + 10 uM cAMP. Data points were fitted with the 
Boltzmann equation (equation 1). Color code for the fitting is the same used for the data points: continuous lines: no cAMP; dashed lines: cAMP. (C) 
Mean ± S.E. of the V1/2 values extrapolated from the fitting of the activation curves. Same color code as in (B). HCN4 N=9; HCN4 + Slr1143 N=9; 
HCN4 + 10uM cAMP N=5; HCN4 + Slr1143 + 10uM cAMP N=6. 
A 
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Since it was clear, at that point, that the enzyme was not able to reverse the effect of saturating 
concentrations of cAMP, the next step was to test the effect of the enzyme under conditions of non-
saturating cAMP concentrations. To do this were performed other experiments, in which the cAMP 
concentration in the pipette was further reduced to 1uM (Fig. 4.7). In these experiments it was possible to 
see a trend for a small difference between the controls and cells expressing Slr1143 R250A. The mean V1/2 
values for this set of experiments were: 
   -102.5 ± 2.9 mV (N=4) in control cells expressing RbHCN4 
  -109.5 ± 1.7 mV (N=5) in cells expressing Slr1143 R250A 
  -95.9 ± 2.6 mV (N=8) in control cells expressing RbHCN4 with 1 uM cAMP in the pipette solution 
  -102 ± 2.2 mV (N=12) in cells co-expressing Slr1143 R250A with 1 uM cAMP in the pipette solution 
 
 
Fig. 4.7 Effect of 1uM cAMP on the half-activation voltage. Mean ± S.E. of the V1/2 values from experiments with 1 uM cAMP. Black circle: HCN4 
(N=4); Blue circle: HCN4 + Slr1143 (N=5); Empty Black circle: HCN4 + 1 uM cAMP (N=8); Empty blue circle: HCN4 + Slr1143 + 1 uM cAMP (N=12). 
 
The results so far suggested that the critical point for seeing the antagonistic effect of c-di-GMP on cAMP 
mediated HCN channel gating was related to the concentration ratio of the two cyclic nucleotides in the 
cytoplasm. I assumed that what had been seen in these experiments was due to a diffusion problem. The 
pipette solution is prepared according to intracellular ion concentrations but when the membrane is 
broken, i.e. the pipette content is in direct contact with the cytoplasm, small molecules can diffuse from 
the latter into the pipette (Pusch and Neher, 1988). When no cAMP was added to the pipette solution, both 
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the c-di-GMP synthesized by Slr1143 R250A and the endogenous cAMP equally diffused into the pipette: in 
this case it was still possible to see an effect of the c-di-GMP binding to the CNBD. When extra cAMP was 
added to the pipette solution the second messenger diffused constantly from the pipette into the 
cytoplasm. Within minutes the cytoslolic cAMP concentration equilibrated with the concentration of cAMP 
in the pipette. The c-di-GMP messenger, in contrast, was diffusing from the cytoplasm to the pipette, which 
means that it was rapidly diluted in the cytosol.  
To circumvent this problem I decided to continue with the photo-activated enzyme and search for 
conditions e.g. light intensity, wavelength, exposure time that might allow robust production of c-di-GMP. 
This should affect at least the binding of endogenous cAMP to the CNBD and modulate in this way cAMP 
gating. 
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4.2 Experiments with a light-activated bacterial diguanylate cyclase. 
The BphS-1 DNA was a generous gift form Prof. Gomelsky, Wyoming University. This is a chimera composed 
by the photo-switch of the pytochrome BphG plus Slr1143 as the effector domain. The latter does not have 
the aforementioned R250A mutation. Given the results from Chapter 4.1, I decided to introduce the 
mutation in this construct (now called BphS) and to move it into the pCAG-IRES-TdTomato plasmid. The 
mutated construct was obtained in the same manner as that used for Slr1143: overlapping-PCR with 
primers for AQUA cloning and for mutagenesis. The insert was then integrated in the plasmid by AQUA 
cloning and positive colonies were screened via colony-PCR. 
Since it was already known that BphS can have some dark activity (Ryu and Gomelsky, 2014), it was 
important to verify that this dark activity could not influence the voltage dependence of the channel in a 
light-independent manner. To estimate this dark effect, HEK293T cells were transfected with 1µg of HCN4  
+ 0.5 µg of BphS and 1µg of HCN4 + 0.5 µg of GFP as controls. 
After 18 hours of cultivation, the HCN4 activity was estimated by patch clamp recordings. Cells were 
measured as in Fig. 4.8 A in the whole cell configuration: voltage-clamp protocols with negative voltage 
steps were applied to the cells to activate and measure HCN4 currents. Tail current values were used again 
to assess the voltage dependency of the channel. A comparison of the activation curves obtained from 
BphS-expressing cells and from control cells showed that the two voltage dependencies are almost 
indistinguishable (Fig. 4.8 B). 
Consequently also the estimated V1/2 values from Boltzmann fits were the same: -104 ± 1 mV for the 
controls (N=14) and -103 ± 0.8 mV for BphS-expressing cells (N=12) (Fig. 4.8 C). The results of these 
experiments showed that  the dark activity of the enzyme did not affect the channel opening in any way. 
After this important control, current measurements were performed on cells which were exposed to red 
light. For these experiments, cells were grown and transfected in a medium that did not contain phenol 
red. This should prevent any kind of interference between the medium and the light. As an irradiation tool, 
I used a custom made array of LEDs (10x15 cm, c.a. 300 LEDs) with an emission maximum at 660 nm; six 
petri dishes could be positioned on this array. The LED array was connected to a timer, which allowed a 
regulation of the light/dark cycles (Fig. 4.9). In the present case a continuous cycle of 20 seconds of light 
and 90 seconds of dark was used for stimulation. The light/dark cycle was recommended by prof. 
Gomelsky. 
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Fig. 4.8 Monitoring the dark activity of BphS. (A) Exemplary current traces obtained by application of voltage protocols in control and BphS-
expressing cells. Tail currents (recorded at -40 mV) of each current family are enlarged and reported on the right for each measurement. (B) 
Normalized tail current amplitudes plotted as a function of the preceding test voltage. Black empty squares: HCN4; Red empty squares: HCN4 + 
BphS. Data points were fitted with the Boltzmann equation (equation 1). Color code for the fitting is the same used for the data points. (C) Mean ± 
S.E. of the V1/2 values of HEK293T cells expressing HCN4 or co-expressing HCN4 + BphS. Black squares: HCN4 (N=14);  Red squares: HCN4 + BphS 
(N=12). 
 
The set up was constructed in such a way that the cells were not in direct contact with the LEDs: empty 
petri dishes were used as a “spacer” between the dishes with cells and the light source. In addition to the 
timing, also the light intensity of the LED array could be regulated. The initial experiments were planned 
with a long light exposure (hours). This extreme exposure should provide information on whether the 
system results at all in a measurable response of the HCN4 currents. In the next step the treatment should 
then be adapted with respect to light intensity and exposure.  
A 
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Fig 4.9 Scheme of the LED apparatus. The LED array was connected to a timer to regulate light/dark cycles. With a knob it was possible to regulate 
the light intensity. On/off button allowed to use continuous light when needed. 
 
The light produced by the LED array turned out to have a much lower intensity than the one used to 
activate the protein in previous studies (Ryu and Gomelsky, 2014). However we found that the light 
exposure of HEK293T cells resulted, after an overnight incubation (15 hours), always in cell death. This 
occurred regardless of the distance, created by the aforementioned spacer, between the cells and the LED 
plate; cells died with one, two or four empty petri dishes as a spacer. To avoid cell death and to obtain 
living cells for some measurements, I decided to leave the cells on the LED plate for shorter periods of time; 
two empy petri dishes were employed as spacer. 
As a first short irradiation time, a period of 1 hour was tested. Worth mentioning is that this time describes 
the length of exposure over which the cells were treated with the aforementioned alternating light/dark 
cycles. Cells treated in this manner turned out to be difficult for obtaining good seals for patch clamp 
recordings. Only a small number of cells were suitable for good whole-cell measurements. In those cells it 
was possible to measure HCN4 type currents slowly activating at negative voltages (Fig. 4.10 A). The  
respective tail currents were used as in Fig. 4.10 B for construction of activation curves. A scrutiny of the 
activation curves implied that light exposure did not affect the voltage dependency of the channel. This 
visual impression was confirmed by the V1/2 values, which were obtained from fitting of data with the 
Boltzmann function (Fig. 4.10 C). For control cells the average V1/2 was -100.1 ± 0.9 mV (N=16) and for 
irradiated BphS-expressing cells it was -102.1 ± 1.1 (N=8). 
In subsequent experiments it was intended to improve the expression of the light sensitive protein by 
increasing the amount of transfected BphS DNA (from 0.5 µg to 0.75 µg). Additionally, the activity of the 
protein was increased by lengthening the exposure time of up to two hours. An analysis of HNC4 currents in 
cells, which were treated in this manner, showed no effect of light exposure (Fig4.10 A, B and C). The 
average V1/2 value of HCN4 currents in cells transfected with 0.75µg of BphS and kept in pulsed light for one 
hour was -97.8 ± 0.7 mV (N=5). Also extending the light exposure to two hours caused no significant shift in 
the V1/2; the mean V1/2 value in these cells was -98.9 ± 1.1 mV (N= 4). V1/2 values for control cells of these 
experiments are included in the aforementioned mean value for control cells: -100.1 ± 0.9 mV (N=16). Cells 
kept on the LED plate for more than two hours were impossible to be measured. 
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Figure 4.10. Expreiments with 660 nm light. (A) Exemplary currents  elicited  by voltage protocols in different cells (transfection and treatment 
reported on each). Tail currents (recorded at -40 mV) of each current family are enlarged and reported on the right for each measurement. (B) 
Normalized tail current amplitudes plotted as a function of the preceding test voltage. Black empty circles: HCN4; Red empty squares: HCN4 + 0.5 
µg BphS-1hour irradiation; Brown empty triangle: HCN4 + 0.75 µg BphS-1hour irradiation; Violet empty diamonds, HCN4 + 0.75 µg BphS-2hours 
irradiation. Data points were fitted with the Boltzmann equation (equation 1). Color code for the fitting is the same used for data points. (C) Mean ± 
S.E. of the V1/2 values extrapolated from the fitting of the activation curves. Same color code used in (B); HCN4 N=16; HCN4 + 0.5 µg BphS-1hour 
irradiation N=8; HCN4 + 0.75 µg BphS-1hour irradiation N=5; HCN4 + 0.75 µg BphS-2hours irradiation N=4.  
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At this point I decided to design a new irradiation device. This LED array should provide a higher irradiance 
without killing the cells. In a first step I tested the possibility to increase the LEDs irradiance by increasing 
the applied voltage. This strategy was not successful because the voltage used for experiments in Fig. 4.10 
was already close to the tolerance level of the LEDs. Moreover, it turned out that the array of many parallel 
LEDs was producing a lot of heat. The heat was presumably the reason why the cells where dying after 
some hours on the LED array, even if they were not directly in contact with the LEDs. 
To increase the light irradiance, new and, more powerful LEDs (1W) were purchased (660 nm LEDs from 
LumenLaden). To reduce heat exposure of the cells a plastic support with holes in which 35 mm petri could 
fit was designed. The LEDs were fixed with a specific glue on an aluminum plate, which improved the heat 
dissipation. The plastic support was located above the LED array and the distance between the two could 
be adjusted and modified with four screws. The whole structure was organized in such a way that each LED 
was located under the center of a petri dish (Fig. 4.11). The new device was able to generate a maximal 
light at an higher irradiance of up to 2 W/m2 (with the previous device was only 0.2 W/m2). 
 
Fig. 4.11 New irradiation device. With this irradiation device it was possible to achieve an higher irradiance and much better heat dissipation. 
 
Once the new device was ready, also a newer version of BphS became available: the construct had been 
codon-optimized for expression in mammalian cells by prof. Gomelsky’s group. The new BphS DNA was 
inserted into a pCDNA plasmid, under the control of a CMV promoter and was followed by an auto-
cleavage sequence of the 2A family (Wang et al., 2015). The 2A self-cleaving peptides are a family of  
oligopeptides located between two proteins that can undergo self-cleavage to generate mature proteins. 
The cleavage site is located between the last two amino acid of the oligopeptide: a glycine, that will 
become the last amino acid of the first protein, and a proline that will be the first residue of the second 
protein (Wang et al., 2015). The 2A sequence separated BphS from a c-di-GMP phosphodiesterase called 
YhjH that should maintain a low concentration of c-di-GMP in the dark. It was expected that the codon 
optimization should allow a much higher expression of the BphS gene so also the dark activity of this 
construct should be improved. It was already known that the YhjH protein is able to lower, as a counter-
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player of the cyclase, the problem of unwanted dark activity (Ryu et al., 2017 and 2014). The multi-genes 
expression system Bphs-2A-Yhjh from now on will be called BphSOpti. 
During the course of the experiments, other groups had already tried to express the BphSOpti multi-genes 
in mammalian cells. Publications from these laboratories provided useful information for the present 
endeavor. Shao and colleagues published a study in which they expressed BphSOpti in HEK293T cells to try 
to regulate the expression of a gene of interest (Shao et al., 2017). The cyclic di-nucletide produced in a 
light dependent manner bound the STING protein, which then activated a signaling cascade resulting in 
activation and nuclear traslocation of the transcription factor IF3. The gene of interest was under the 
control of a promoter engineered to contain IF3 binding site. They were able to see a light-driven 
expression of the desired protein within 2-4 hours. Moreover they showed that the presence of the Yhjh 
phopshodiesterase was actually necessary to keep a low concentration of c-di-GMP in the dark. 
The new plasmid containing the multi-genes expression system BphSOpti was therefore used to transfect 
HEK293T cells, taking advantage of the new information in terms of irradiation time and intensity. Since the 
new plasmid did not contain any fluorescent protein, I prepared the following co-transfection protocol: 1 
µg of HCN4 + 0.75 µg of BphSOpti + 0.3 µg of GFP/µg other DNAs. The latter was an amount of GFP, which 
already proved to be good for triple transfections; these experiments had been performed by colleagues in 
the lab. In this case I preferred to use the GFP because it is a bit brighter than the TdTomato. Irradiance was 
set to 2 W/m2 and 24 hours after transfection cells were exposed for 2.5 hours to pulsed red light. 
The first measurements with cells, which expressed the new codon-optimized enzyme and which were 
exposed to the new light device, exhibited no perceivable response to red light. Tri-transfected cells 
showed weaker membranes and were therefore hard to measure. Recordings from cells suitable for patch 
clamp recordings, showed HCN4 type currents that were used for further analysis (Fig 4.12 A). An analysis 
of the activation curves, which were as in Fig. 4.12 B  constructed from the tail currents, showed no 
appreciable difference between the control cells and tri-transfected cells exposed to red light. Also in this 
case the fitting of the data reveled no difference in the average V1/2 values between the control cells 
expressing HCN4 and the BphSOpti-RbHCN4 co-transfected cells (Fig 4.12 C). The V1/2 value was -102.1 ± 1.2 
mV (N=3) in control cells and  -103 ± 2.5 mV (N=4) in the BphSOpti-RbHCN4 expressing cells. Notably the 
number of tested cells was, because of the problems of obtaining robust measurements, rather low. But 
the data indicated already that an effect of a light regulated modulation of HCN4 channels by BphS would 
be, if any, very small.  
The first results were not encouraging and asked for additional experiments in which other experimental 
parameters are tested. One critical parameter could be the exposure. According to Shao et al. exposure 
time between 2 and 48 hours could be suitable for testing  (Shao et al., 2017). But since these experiments 
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are very time consuming and the electrical recordings of light treated cells are difficult, I decided to change 
the strategy. Notable the recording of HCN4 currents is an indirect assay system for the production of c-di-
GMP. Hence it is not clear whether the absence of response of HCN4 gating in HEK293T cells exposed to 
light is caused by an insensitivity of the channel to the signaling molecule or whether light is not stimulating 
the synthesis of c-di-GMP. Under these circumstances, it would be more useful to find a way of quantifying 
the concentration of c-di-GMP in the cytosol of transfected HEK293 cells after red light irradiation. The 
quantification of the c-di-GMP will be explained in the following chapters.  
 
 
 
Fig. 4.12 Expression of BphSOpti. (A) Exemplary current traces obtained by application of voltage protocols in control and BphSOpti-expressing 
cells. Tail currents (recorded at -40 mV) of each current family are enlarged and reported on the right for each measurement. (B) Normalized tail 
current amplitudes plotted as a function of the preceding test voltage. Black empty squares: HCN4; Red empty squares: HCN4 + BphSOpti-2.5h 
irradiation. Data points were fitted with the Boltzmann equation (equation 1). Color code for the fitting is the same used for the data points. (C) 
Mean ± S.E. of the V1/2 values of HEK293T cells expressing HCN4 or HCN4 + BphSOpti. Black dots: HCN4 (N=3); Red dots: HCN4 + BphSOpti-2.5 h 
irrdiation (N=4). 
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4.3 Quantification of the synthesis of c-di-GMP by ELISA assay. 
As previously mentioned, I decided that it was necessary to quantify the c-di-GMP produced by the BphS- 
construct after different times of light exposure. By doing this it should be possible to understand the 
relationship between the irradiation period and the concentration of c-di-GMP in the cytoplasm of a BphS-
expressing cell. From the results obtained in Chapter 4.1 with the constitutively active enzyme Slr1143 
R250A, it was already anticipated that the latter was able to generate sufficient cyclic di-nucleotide for 
affecting the HCN4 voltage dependency. For this reason the constitutively active enzyme can be considered 
as a very good positive control. At the same time the cyclic di-nucleotide produced by this construct serves 
as an internal reference for the desired minimum amount of c-di-GMP. I decided to quantify the enzyme 
activity by performing an ELISA assay, which is a test commonly used to detect the presence of a molecule 
of interest and to quantify its concentration in biological samples like cell culture supernatants, tissue 
homogenates, plasma etc. 
An ELISA kit specific for quantification of c-di-GMP is available from EIAab and is based on the competitive 
immunoassay technique. In this type of ELISA the sample containing the substance of interest is mixed with 
a fixed amount of the same molecule whereby the latter carries a label. To calibrate the system, samples 
with known concentration of the analyte are prepared by diluting a stock solution provided with the kit.  
One of these standard solutions contains only the dilution buffer, which serves as the “blank” of the assay. 
The standards are mixed with the labeled molecule as well. The standards and the samples are loaded into 
a special multi-well plate in which the wells have been pre-coated with an antibody able to bind the 
analyte. In this manner, the molecules from the samples/standards and the labeled cyclic di-nucleotides 
will compete for binding sites on the antibodies located on the bottom of each well. The binding of the 
marked antigen to the antibody can be monitored optically as it will react with the buffers subsequently 
added to each well, changing their color to yellow. So the concentration of the molecule of interest in the 
samples is inversely proportional to the color change: the less colored a well, the higher the concentration 
of the analyte in the sample loaded in that well. The absorbance in the yellow range of the spectrum is 
measured for each well using a special spectrophotometer, designed for multi-well plates. The absorbance 
value of the blank has to be subtracted from all the others to apply the blank correction. The standards are 
used to create a concentration/absorbance calibration curve from which the unknown concentrations of 
the samples can be extrapolated. This type of ELISA was successfully used by Shao and colleagues to 
quantify c-di-GMP synthesis in HEK293T cells (Shao et al., 2017, Fig. 4.13 A). I used this paper as a reference 
for expression of BphS in HEK293T cells. 
HEK293T cells were transfected with the same amount of DNA used for experiments in chapter 4.2: 1µg 
HCN4 + 0.75 µg BphSOpti +0.3 µg of GFP/µg other DNAs. Slr1143 R250A was used as a positive control: the 
respective cells were transfected with 1 µg of HCN4 + 0.5 µg of Slr1143 R250A. The transfections presented 
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in this chapter were performed with the calcium phosphate protocol (see Materials and Methods). Here are 
reported the ratios between the different plasmids, which are the same described in chapter 4.2, but the 
amount of DNA was scaled up for this type of transfection (1µg = 6µg). 24 hours after transfections, the 
transfection efficiency was checked under a microscope. The transfection efficiency was generally 30-40%. 
Half of the petri dishes containing the cells expressing BphSOpti were brought in a different incubator and 
exposed to pulsed red light (2 W/m2) for different periods, namely 3, 6 or 9 hours. The other petri dishes 
were kept in the dark for the same amount of time. Slr1143-transfected cells were used for the preparation 
of cell extract samples right after post-transfection at 24 hours. One dish containing BphSOpti-transfected 
cells was used to prepare a sample right after the post-transfection at 24 hours: the t=0 of the experimental 
timeline. Samples of cytoplasm content of transfected HEK293T cells were prepared as described in 
Matherials and Methods. Briefly, cells were collected and centrifuged to obtain a pellet, which was re-
suspended in 500 uL of PBS. The cell concentration of this suspension was determined with a cell counter 
and this information was used to further dilute the cells to a final concentration of 1x106 cells/mL. Each cell 
suspension underwent three freeze-thaw cycles (-20°C to room temperature (RT)) to break the membranes 
and make the cells release their intracellular component. Samples were centrifuged and the supernatant 
was transferred into a new tube and kept at -20 °C. A scheme of the procedure is reported in fig. 4.13 B. 
 
         
Fig. 4.13 Scheme of Elisa preparation protocol. (A) Results obtained by Shao and colleagues using the same kit that I used in this work. Shao and 
coworkers showed the concentration values of c-di-GMP in cytosol extracts of cells expressing BphS or the BphSOpti multi-gene system (Shao eta 
al., 2017) (B) Schematic representation of the preparation of the cell extract samples. 
 
In the next step the samples and the standards were loaded in the multi-well plate together with biotin-
labeled c-di-GMP (two wells for each sample/standard). Like mentioned before, the latter competes with 
the cyclic di-nucleotide from the samples for binding to the antibody coating during an incubation at 37°C. 
After washing away the unbound molecules, avidin conjugated to Horseradish Peroxidase (HRP) was added 
to each well. Avidin is known to strongly bind the biotin so, after another incubation at 37°C, the enzyme 
HRP would be bound to the biotin-labeled c-di-GMP. The substrate for HRP (3,3’,5,5’-tetramethylbenzidine 
or TMB) was added, together with hydrogen peroxide (H2O2), in each well and the reaction with peroxidase 
developed an intense blue color. The enzyme-substrate reaction was terminated by the addition of a 
sulphuric acid solution that also changed the color from blue to yellow. The color change was measured 
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spectro-photometrically at a wavelength of 450 nm. Absorbance values of the standards were averaged, 
plotted as a function of the Log10 of the c-di-GMP concentrations and fitted with a four parameter logistic 
curve (4PL) (Equation 2): 
             
        
    
 
  
 
  
where A1 is the maximum value and A2 is the minimum value that can be obtained.  X0 gives the point of 
inflection (i.e. the point on the S shaped curve halfway between A1 and A2) and p the slope of the curve 
(related to the steepness of the curve at point c) (Fig. 4.14 A). The unknown concentration of c-di-GMP in 
the samples was then determined with this curve. 
  
 
 
 
Fig 4.14 First quantification of c-di-GMP content in HEK293T cells. (A) Blank-subtracted absorbance values of the standards (red dots) measured at 
450 nm plotted as a function of their known concentrations (in logarithmic scale). Data points were fitted with a 4PL function (Eq. 2). (B) 
Concentration values of different cell extracts extrapolated from the calibration curve in (A). Each sample was loaded in two wells of the plate to 
obtain double absorbance measurements and therefore two concentration values for each sample: in the graph are reported mean values ± SE. An 
extract of cells expressing Slr 1143 R250A was prepared as a positive control of the test (blue) 24 hours after transfection. At the same time, an 
extract of cells expressing BphSOpti was prepared to serve as the t=0 (black and white) of the experimental timeline. From that moment, two 
extracts of BphSOpti-expressing cells were prepared every 3 hours: one using cells kept in the dark (black) and one using cells exposed to light (red). 
(C) Exemplary standard column for competitive ELISA test. Left, loading scheme; right, color change gradient. 
 
The results of the assay were negative in the sense that they did not reveal any effect of red light exposure 
on the c-di-GMP concentration (Fig 4.14 B). The c-di-GMP concentration in each sample was lower than the 
lowest standard concentration (1.1 nM). This means that all the concentration values were below the 
detection level of the assay. Different from what was expected from the experiments in Chapter 4.1, also 
the positive controls with the constitutively active Slr1143 R250A revealed c-di-GMP concentrations below 
the detection level. From this result we reasoned that the assay system may have not been appropriate for 
measuring the expected elevation of c-di-GMP in the cells. It has been already mentioned that each of the 
eight standards was loaded into two wells, one in the first column of the plate and one in the last after all 
A B 
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the samples. This procedure provides two values for each concentration and offers an internal check for the 
precision of the performance of the assay. A comparison of these internal standards showed that both gave 
about the same color gradient as the one reported if Fig. 4.14 C: a very pale yellow turned into orange 
according to the decrease in concentration of the standards (from 72.4 to 1.1 nM). This means that the 
procedure of the assay is sufficiently robust; even some pipetting error between individual samples should 
not compromise the whole test. Based on the results of these experiments and on the considerations on 
the assay system, we reasoned that the problem could have been an un-sufficient cell lysis. An inefficient 
membrane disruption may have prevented the release of cytosolic c-di-GMP from the cells into the 
supernatant. 
To improve the assay I contacted prof. Haifeng Ye, the corresponding author of the paper by Shao et al. 
(Shao et al., 2017),  to ask for advice on experimental details of the ELISA assay, which were not spelled out 
in the paper. It turned out that, despite of what they wrote in the paper, they did not follow the 
instructions in the manual. Instead they used a lysis buffer from another ELISA kit to break the cell 
membranes. I then decided to perform a chemical lysis as well. I prepared two types of lysis buffer. For the 
first one I took advantage of the knowledge of my colleagues that lysed human cells with the detergent 
Triton (1%) to analyze their protein content. The second buffer was kindly suggested by prof. Haifeng Ye. 
He recommended a buffer used in another paper, in which the authors were trying to extract cytosolic c-di-
GMP from HEK cells (Folcher et al., 2014). This buffer contained acetonitrile, methanol and H2O (2:2:1). 
Three sets of samples were prepared in order to achieve a sufficient cell lysis. The preparation of the first 
set of samples followed the instruction manual of the kit, i.e. including a re-suspension of the cells in PBS. 
But unlike in the experiments in Fig. 4.14 the freeze-thaw cycles were performed from -80°C to RT. The 
second set of sample was prepared by lysing the cell with Triton buffer. In the third attempt an Acetonitrile-
Methanol buffer was used to prepare the cells. Detailed protocols and buffer contents can be found in 
Materials and Methods. In this round of experiments also samples of un-transfected cells were prepared as 
an additional negative control. Each sample, as well as the standards, were loaded two times on an ELISA 
plate. Also in this assay, the color gradient of the standards was the expected one with little variations 
between the values of the two dual recordings. The absorbance data points of the standards were well 
fitted with a 4PL function (Equation 2) providing the calibration curve. Unlike in the experiments reported 
in Fig. 4.14, modified lysis procedure provided some interesting differences between the experimental 
samples (Fig. 4.15). 
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Fig 4.15 Assay of c-di-GMP concentration in HEK293T cells after lysis with different buffers. (A) Blank-subtracted absorbance values of the 
standards (red dots) measured at 450 nm plotted as a function of their known concentrations (in logarithmic scale). Data points were fitted with a 
4PL function (Eq. 2). (B), (C) and (D) In these three graphs are grouped the concentration values of cell extracts obtained by performing the lysis in 
PBS (B), in 1% Triton buffer (C) and in Acetotintrile-Methanol buffer (D). Each sample was loaded in two wells of the plate to obtain double 
absorbance measurements and therefore two concentration values for each sample: in the graph are reported mean values ± SE. In each graph the 
samples are identified by the same colors and names used in Fig. 4.14 with the addition of untransfected cell extracts (green).  
The first set of samples provided once again a c-di-GMP concentration for almost every sample less than 
1.1, i.e. below the detection range (Fig. 4.15 B). This seemed to confirm again that, despite what is reported 
in the instruction manual, freeze-thaw cycles in PBS are not sufficient for a good membrane disruption. The 
samples from cells lysed with the Triton buffer turned out to have c-di-GMP concentrations appreciably 
above the background value (Fig. 4.15 C). As mentioned before, the amount of c-di-GMP synthesized by 
Slr1143 R250A should be taken as a reference for the desired synthesis activity. The concentration values 
obtained with BphSOpti-expressing cells were very similar to that of cells transfected with Slr1143 R250A: 
this suggested that the two constructs were synthesizing the same amount of c-di-GMP. An comparison of 
the concentration of different extracts of BphSopti-expressing cells, could give information about light 
dependency of the c-di-GMP production. The measurements provided concentration values between c.a. 3 
and 5 nM for all the samples irrespective of whether the cells had been exposed to the light or not. Notably 
the estimated concentration value for the samples prepared from untransfected cells was in the same 
range: this may suggest that the light regulated enzyme was not generating c-di-GMP above the resting 
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concentration of cells. However, the instruction manual of the kit  reports that a chemical lysis may cause 
unexpected ELISA results by a cross reaction between the lysis agent and the assay system. For this reason 
it was assumed that the measured values might be affected by an interaction between the buffer and the 
rest of the ELISA components.  
With the third lysis buffer I was able to obtain the best results (Fig. 4.15 D). First of all the concentration 
values were on average 6 and 30 times bigger than the previous approaches with Triton and PBS 
respectively. This indicated that the cell lysis was more efficient and that the lysis buffer did presumably not 
interfere in a negative manner with the assay.  The estimated c-di-GMP concenatrations were in the range 
of 15 and 32 nM. An overlook of the results obtained with different types of samples indicated that there 
was no significant difference between the concentration of the second messenger in the cells transfected 
with Slr 1143 R250A and its light-dependent counterpart. The cytoplasm sample from cells transfected with 
BphSOpti, 24 hours after transfection, turned out to have the same c-di-GMP concentration as the positive 
control. The lack of light regulation could be confirmed also by comparing the BphSOpti samples: there was 
no concentration difference on whether cells were exposed to the light or not. In this assay, the 
concentration value obtained from the untransfected cells was very close to the minimum value of the 
calibration curve. This result is reasonable for cells that do not express any digaunylate cyclase; together 
with the expected behavior of the standards, this is a proof of the robustness of the assay. 
The results of the experiments suggested that the concentration values obtained with the third lysis 
method were the most reliable because they were all in the detection range of the assay, which did not 
seem affected by the buffer (as indicated by the negative control). This assay showed that the c-di-GMP 
levels produced by cells expressing Slr1143 R250A and BphSOpti are basically the same. Notably also the 
samples prepared at t=0, i.e. without any light stimulation, contained c-di-GMP at a concentration similar to 
that of the positive control (Fig 4.15 D). These results suggested the following interpretation: the BphSOpti 
system was actually able to synthesize c-di-GMP in a similar manner to the Slr1143 R250A enzyme. This 
synthesis however did not exhibit any light-regulation: between paired samples, which were exposed for 
the same length of time to light or dark,  the assay showed no appreciable difference in terms of 
concentration of the second messenger. The data seemed to describe a homeostatic system in which c-di-
GMP synthesis by BphS in the dark is not antagonized by the activity of Yhjh, which degrades the second 
messenger. The system presumably reaches an equilibrium in which the phosphodiesterase is not able to 
counteract the construct activity. 
The assay of Fig. 4.15 D with the lysis in Acetonitrile-Methanol was repeated a second time to confirm the 
results. In this experiment the samples were loaded three times on the multi well plate in order to have 
more absorbance measurements. Moreover, the first sample from light-exposed cells was collected at 1.5 
hours to test whether a shorter exposure time could beneficial for detecting a difference between light and 
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dark. The calibration curve from this experiments looked better, i.e. more S-shaped, compared to that from 
the previous assay (Fig. 4.16 A). The c-di-GMP concentration values obtained from this second test were 
more similar to data from Shao et al. (reported in Fig 4.13). All the samples had a concentration between 8 
and 1 nM (Fig. 4.16 B). The sample taken from untransfected cells showed a concentration correspondent 
to the curve minimum, consistent with the fact that no c-di-GMP molecules are supposed to be synthesized 
in those cells. Also in this assay the c-di-GMP levels in the cell extracts of BphSOpti-expressing cells were 
very close to the positive control.  
A comparison between the results obtained in this experiment and those from the previous quantification 
in 4.14 D indicated a considerable variability between the two assays, even though the conditions were the 
same in terms of transfection protocol, lysis buffer and assay protocol. In this second experiment the 
concentrations were lower and the shape of the calibration curved was different. This variability between 
two assays performed in the same conditions may indicate that this quantification system is very sensitive 
to indiscernible variations in the procedure. Nevertheless, in both the experiments the concentration of the 
positive control was always in between the detection range while that of untransfected cells sample 
corresponded to the minimum of the calibration curve. For this reasons the test was considered robust 
enough to get general information about the behavior of the enzymes. The important conclusion was the 
lack of light regulation. Cells kept in the dark or exposed to the light were synthesizing the same amount of 
c-di-GMP, that was similar to that of cells expressing Slr1143 R250A.  
 
 
 
Fig 4.16 Assay of c-di-GMP concentration in HEK293T cells after lysis with Acetonitrile. (A) Blank-subtracted absorbance values of the standards 
(red dots) measured at 450 nm plotted as a function of their known concentrations (in logarithmic scale). Data points were fitted with a 4PL 
function (Eq. 2). (B) Concentration values of different cell extracts extrapolated from the calibration curve in (A). Each sample was loaded in three 
wells of the plate this time: in the graph are reported mean values ± SE. Samples are identified by the same colors and names used in Fig. 4.15 D. 
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The results of the ELISA assay seemed to contradict the data collected with the electrophysiological 
experiments and reported in Chapter 4.2, in which no effect on the voltage dependency of the HCN4 
channel was observed in cells co-expressing the channel and the construct. If the optimized BphS protein is, 
according to the results from the ELISA assays, able to synthesize as much c-di-GMP as Slr1143 R250A  one 
would expect an effect on the HCN4 currents in HEK293T cells co-rasfected with the channel and the 
construct. 
In the light of these results I decided to repeat the electrophysiological measurements with BphSOpti 
transfected HEK293 cells. By repeating these experiments I wanted to exclude the possibility that the 
previous measurements were affected by some external factors, such as the number of culture passage, 
temperature in the room etc. HEK293T cells were transfected as for the ELISA assays and the experiments 
reported in chapter 4.2 in petri dishes. 24 hours after the transfection half of them were exposed to the 
light for 1.5 hours in order to be able to compare the results from electrophysiology with those from the 
ELISAs. The control cells transfected with HCN4 displayed the typical slowly activated inward currents 
previously described (fig.4.17 A). Tail currents amplitudes were plotted as a function of the voltage of the 
test pulse to construct the activation curves. The V1/2 values were obtained from a fit of the activation 
curves with the Boltzmann equation (Equation 1). Representative activation curves from cells expressing 
different constructs of interest are shown in Fig 4.17 B. The average V1/2 value of the control cells in this set 
of experiments was -103 ± 0.7 mV. No significant difference, neither in the currents kinetics or in the 
voltage dependency of the channel, was observed between the controls and the cells expressing the 
BphSOpti enzyme after incubation in the dark or in red light. As a consequence, also the V1/2 values found in 
these two cell populations were not significantly different from the control cells. For cells kept in the dark 
the average V1/2 was -102.6 ± 0.9 mV, while for their counterpart exposed to light it was -100 ± 1 mV (Fig. 
4.17 C). 
Data from the electrophysiological recordings and the ELISA remained contradictory. To have a better 
understanding on whether BphSOpti was actually producing some cytosolic c-di-GMP, which is sufficient to 
affect HCN4 gating, I developed an alternative manner to quantify the cyclic di-nucleotide. I reasoned that 
the large variability of the results between different ELISA assays of c-di-GMP (Fig. 4.15 D and 4.16 B) may 
indicate that this assay system is not sufficiently robust for uncovering small changes in c-di-GMP 
concentration. As an alternative method for measuring c-di-GMP concentrations in cells, I developed an 
immune-fluorescence based assay. With this new method it should be possible to monitor the production 
of c-di-GMP within a single cell. The main advantage of this new method is that no cell lysis is required and 
that the cell would act as a closed and unmodified entity in which the synthesis occurs. In the next chapter I 
will present the technique and the results obtained with it. 
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Figure 4.17. Additional electrophysiological data on HCN4 gating. (A) Exemplary currents elicited by voltage protocols in different cells 
(transfection and treatment reported on each). Tail currents (recorded at -40 mV) of each current family are enlarged and reported on the right for 
each measurement. (B) Normalized tail current amplitudes plotted as a function of the preceding test voltage. Black empty squares: HCN4; Red 
empty triangles: HCN4 + 0.75 µg BphSOpti-1.5 hours of dark; Violet empty diamonds, HCN4 + 0.75 µg BphS-1.5 hours irradiation. Data points were 
fitted with the Boltzmann equation (equation 1). Color code for the fitting is the same used for data points. (C) Mean ± S.E. of the V1/2 values 
extrapolated from the fitting of the activation curves. Same color code used in (B); HCN4 N=6; HCN4 + 0.75 µg BphSOpti-1.5 hours of dark N=7; 
HCN4 + 0.75 µg BphS-1.5 hours irradiation N=5. 
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4.4 Quantification of the c-di-GMP via immuno-fluorescence. 
It had been mentioned in the previous chapter that the measurements of the c-di-GMP concentration in 
HEK293 cells with the ELISA assays were contradictory to the data from electrophysiological experiments. In 
order to better understand if the optimized BphS enzyme can really synthesize sufficient c-di-GMP for 
shifting the activation curve of the HCN4 channel and if this synthesis is light sensitive, I developed another 
system to quantify the concentration of the molecule in human cells. The latter is based on the fact that 
cyclic di-nucleotides can induce the synthesis of Interferon Beta (IFN-β) in cells of the immune system 
(McWhirter et al., 2009; Burdette et al., 2011; Burdette and Vance, 2013). Cyclic di-nucleotides are indeed 
able to bind STING (Stimulator of Interferon Gene), a protein of the Endoplasmic Reticulum (ER) (Burdette 
et al., 2011). STING recruits and activates the TANK binding kinase 1 (TBK1), which, in turn, phosphorylates 
its downstream transcription factor: IFN regulatory factor 3 (IRF3); the latter is a key transcription factor 
required for the induction of IFN-β expression (Burdette and Vance, 2013). A scheme of the pathway is 
reported in Fig. 4.18. 
 
Fig 4.18 Schematic overview of the STING pathway. STING binds cyclic dinucleotides and recruits TBK1. TBK1 interacts with and phosphorylates 
IRF3, which induces its dimerization and translocation to the nucleus. IRF3 binds to promoter elements to induce transcription of INF-β  (Burdette et 
al., 2011). 
 
On the basis of this knowledge, the idea was to estimate the activity of BphSOpti and Slr1143 R250A by 
transfecting them into T cells and monitoring the synthesis of IFN-β induced by the c-di-GMP. The presence 
of the interferon in the cytoplasm of the cells can be detected optically in individual cells by using a specific 
couple of primary and secondary antibodies. A secondary antibody with absorbance/emission peaks equal 
to those of GFP was already present in the lab and successfully used for immune-fluorescence analysis, so a 
compatible primary antibody specific for IFN-β was purchased. Jurkat cells were chosen for these imaging 
experiments because they are an immortalized line of human T lymphocytes commonly used to study T 
cells signaling.  
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Before expressing the heterologous enzymes in Jurkat, we wanted to observe the ability of these cells to 
synthesize IFN-β when immune response is activated. To do this, a sample of Jurkat cells (1.5 x 106 cells) 
was exposed overnight to ImmunoCult, a mix of T cells activators. It was also prepared a similar sample of 
untreated cells that served as negative control, to monitor the basal levels of IFN-β in Jurkat cells. The 
following day, cells were fixated and permeabilized as described in Matherial and Methods. Afterwards, 
they were incubated overnight with the primary antibody and then exposed to the secondary antibody. 
After this preparation, the cells were ready to be imaged on a confocal microscope with light and filters 
suitable for observation of GFP-like signal. Pictures of the two samples were taken for further analysis of 
the fluorescence. In Fig. 4.19 are reported two exemplary images of the treated cells (A) and the negative 
controls (B). The sample of ImmunoCult-treated cells appeared to be heterogeneous. Most of the cells 
were brighter than the control cells, in which the fluorescence was weak and seemed to be localized close 
the membrane. In few treated cells the fluorescence was not so far from that of the controls, which means 
that the immune response was not the same for every cell. The fluorescence intensities of the cells were 
measured with an image analysis software (FIJI), in which the user can define a region of interest (ROI) in an 
image and quantify the brightness in the selected ROI. The software calculates the mean brightness of the 
pixels in the selected ROI giving a value for the Integrated Density (I.D.). ROIs were defined by following the 
borders of each individual cell, obtaining the correspondent I.D. values. The average I.D. for the control 
cells was 2613.3 ± 259.4 (N=36). This value was used as a reference value for the basal level of IFN-β in 
Jurkat cells. The treated cells showed a significantly higher green fluorescence compared to the negative 
controls: the average I.D. was 4753.8 ± 293.8 (N=68) (Fig. 4.19 C). This result suggested that an appreciable 
increase of the IFN-β in the cytoplasm can be detected with this method when the pathway is activated. 
      
Fig. 4.19 Synthesis of INF-β in Jurkat T-cells. (A) Picture of a group of jurkat cells untreated and untransfected. (B) Picture of a group of Jurkat cells 
treated with ImmunoCult overnight. (C) Mean ± SE of I.D. values from control cells (black circles, N=36) and from activated cells (blue circles, N=68). 
B 
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At this point I moved on with the estimation of the activity of the constructs. For this experiments the 
presence of IFN-β could again be detected with the fluorescent tag on the secondary antibody, while the 
transient expression of a construct could be verified by co-transfection with a fluorescent protein. The 
fluorescent tag on the secondary antibody and the co-transfected fluorescent protein should have different 
absorption/emission peaks. In this way it is possible to detect two different signals: the signal emitted by 
the fluorescent protein is an indirect measure of the expression level of the enzyme, while the signal 
emitted by the antibody detects the abundance of interferon in the cytoplasm. It can be assumed that the 
expression of the proteins of interest after transfection with exogenous DNA can vary from one 
transfection to another. Hence also the number of enzymes will vary from cell to cell. For this reason the 
data from each cell can be expressed in a ratiometric manner as the ratio “expression signal/IFN-β signal”. 
A quantitative comparison of the “expression signal/IFN-β signal” ratio from cells expressing Slr1143 R250A 
and BphSOpti can tell whether the light sensitive synthetic protein synthesizes the same ammount of c-di-
GMP as the constitutively active enzyme. The latter hypothesis was suggested from the ELISA 
measurements. In the case of the BphSOpti system, it must be kept in mind that the final concentration of 
c-di-GMP depends on the concerted activity of the cyclase BphS and the phosphodiesterase YhjH. 
I decided to use the TdTomato as a fluorescent protein to monitor the expression of the enzymes since it 
absorbs and emits light at different wavelengths than those of GFP. In a first set of experiments the 
performance of the system was tested with the Slr1143 R250A construct as a positive control. Jurkat cells 
were therefore transfected, using the Lipofectamine, with 0.5 µg of HCN4 + 0.5 µg of Slr1143 R250A. Jurkat 
cells require a transfection protocol different from that used for HEK293T cells (details are found in 
Matherials and Methods). It turned out that a double transfection of the Jurkat cells was very difficult as 
there was no detectable  uorescence in the cytoplasm of the transfected cells. This is a well know 
phenomena in these cells which o en exhibit a transfec on frequency of   10% when transfected with a 
single plasmid. Since these cells are already harder to transfect with a single plasmid, they may not be 
suitable for a double or triple transfection. To circumvent this problem, the cells were transfected with only 
the plasmid containing the construct and the fluorescent protein, without HCN4. 24 hours after the 
transfection the cells were fixated, permeabilized and exposed to the two antibodies. Single Jurkat cells 
were then imaged on a confocal microscope, where the two emission signals (red from the TdTomato and 
green from the antibody) could be observed by using different excitation wavelengths and appropriate 
filter sets. Bright light images were used to check the morphology of the cells. For each cell or group of 
cells, three pictures were taken: one with the light and the filters to see the antibody green signal, one with 
those necessary for the detection of the TdTomato fluorescence and one with unfiltered light. 
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Fig. 4.20 A reports an exemplary set of images from a group of Jurkat cells. The image contains cells that 
emit the red TdTomato signal as well as a strong green fluorescence from IFN-β. The latter was generally 
more intense than the emission in the red signal (blue arrows in the figure). Only a few cells showed a 
different behavior: they emitted a strong red signal from TdTomato and only a poor green signal from IFN-
β. A closer examination of these cells showed that they displayed peculiar features: the red signal was 
diffused throughout the whole cell and the nucleus was undistinguishable from the cytoplasm (like the one 
indicated by the yellow arrow). When examined with the white light, the respective cells exhibited a more 
irregular morphology than other cells; notably Jurkat cells are suspension cells, which are generally 
perfectly round with a very similar size. In some cases, the membranes of the abnormal fluorescent cells 
occurred wrinkled. On the basis of these considerations I assumed that the Jurkat cells, which are displaying 
these feature are unhealthy; for this reason they were not included in the statistical analysis.  
 
         
 
 
Fig. 4.20 The activity of Slr1143 R250A triggers the expression of IFN-β. (A) Exemplary set of pictures taken at the confocal microscope for a group 
of Jurkat cells transfected with Slr1143 R250A. The cells indicated by the blue arrows are a good example of what has been observed in most of the 
cells. They emits a read signal from the TdTomato and a much stronger green signal from the IFN-β. The yellow arrow indicates a cell in which the 
red signal is stronger than the green one. As explained in the text, this type of cells were discarded. (B) I.D. values for the green signal (IFN-β) 
measured in cells transfected with Slr1143 R250A plotted as a function of the I.D. values for red signal (TdTomato) (N=126). To better describe the 
relationship between the two fluorescence intensities, data points were fitted with a linear function (red line). 
 
The fluorescence intensities were again measured with FIJI. To describe the relationship between the 
concentration of the BphS enzyme in a cell and the IFN-β concentration, as an indirect estimation for the c-
di-GMP concentration, the two fluorescent values were plotted in a scatter plot (Fig. 4.20 B) with the red 
signal I.D. values on the x axis and the green I.D. values on the y-axis. The data from this plot show that the 
two values from individual 126 cells exhibit a striking linear relation with a correlation coefficient of +0.98 
A B 
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and a slope of 11 ± 0.2. It is noteworthy that the average I.D. value of the untransfected cells (Fig. 4.19 C) 
corresponds to the smallest values of the curve in Fig. 4.20 B. I reasoned that the higher green fluorescence 
in Slr1143 R250A sample, compared to negative controls, was due to the presence of the exogenous 
enzyme. The results of these experiments suggested indeed that an expression of Slr1143 R250A in Jurkat 
cells triggers the synthesis of IFN-β presumably via an increase in c-di-GMP concentration. The data 
furthermore suggest that the increase in the concentration of IFN-β is a function of the concentration of 
the BphS enzyme. 
In the following set of experiments the same measurements were repeated with the light-regulated 
enzyme. As described in previous chapters, the multi-gene sequence BphSOpti was inserted in a plasmid 
that lacked a fluorescent tag. I then designed an AQUA cloning procedure to introduce after YhjH another 
2A sequence and a Tdtomato, obtaining in this way a single suitable for single transfections of the Jurkat 
cells. Three dishes of cells were transfected: the first one with 1 µg of Slr1143 R250A (to have a positive 
control) and the other two with 1 µg of the new plasmid. 24 hours after the transfection, one of these two 
dishes was exposed to pulsed light for 1.5 hours. After this time, Jurkat cells from the three petri dishes 
were separately collected and prepared for the staining. The cell samples were then imaged on the 
confocal microscope, where it was possible to observe a high number of cells emitting the TdTomato signal 
in each of the three dishes. Like in the previous assay, these cells also emitted in the green spectrum. 
Pictures were taken at the microscope and analyzed with FIJI to investigate the fluorescence intensities.  
First, I analyzed the fluorescence of the cells transfected with the positive control Slr1143 R250A. Red 
fluorescence from the TdTomato was linearly correlated with the green fluorescence from IFN-β 
(correlation coefficient +0.99; m = 14 ± 0.2; N=40) (Fig. 4.21 A). The vast majority of the I.D. values were 
larger than the average value of the negative control. In cells, which were expressing BphSOpti but kept in 
the dark the two fluorescent intensities exhibited the same linear relationship (fig 4.21 B) with a correlation 
coefficient of +0.96 and a slope of 15.6 ± 0.8 (N=27). These data seemed to indicate that the enzyme 
activity in the dark is already comparable to that of the positive control Slr1143 R250A. The same analysis 
was done for the cells expressing BphSOpti and treated with pulsed light. The two fluorescence intensities 
showed also in this case a linar relationship (Fig 4.21 C). Even if data points were more dispersed, a linear 
equation was perfectly able to follow the trend of their distribution: the correlation coefficient was +0.86 
and the m value was 17.6 ± 2 (N=28). For this cell population the activity of the enzyme seems to be similar 
to that observed in cells kept in the dark: the slopes of the two lines were not too different (Fig. 4.21 D). 
The results of this analysis indicated that light had no positive effect on the production of IFN-β and hence 
on the underlying production of c-di-GMP. 
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If we take the correlation between the concentration of the enzyme and the synthesis of IFN-β as an 
indirect estimate for the BphS enzymatic activity, the data confirm the results from the ELISA assay. First, 
BphS is able to synthesize as much c-di-GMP as its constitutively active counterpart even if its effect on the 
HCN4 channel could not be observed in HEK293T cells. Second, the activity of BphS does not seem to be 
affected by red light.  
 
 
Fig. 4.21 Estimation of the BphS activity in light and dark. (A) I.D. values for the green signal (IFN-β) measured in cells transfected 
with Slr1143 R250A plotted as a function of the I.D. values for red signal (TdTomato) (N=40). (B) I.D. values for the green signal (IFN-
β) measured in cells transfected with BphSOpti and kept in the dark, plotted as a function of the I.D. values for the red signal 
(TdTomato) (N=27). (C) I.D. values for the green signal (IFN-β) measured in cells transfected with BphSOpti and exposed to light for 
1.5 hours, plotted as a function of the I.D. values for the red signal (TdTomato) (N=28). Data points in (A), (B) and (C) are fitted with 
a linear equation. (D) Linear equations used to fit the data points in (B) (grey) and (C) (red). 
 
It has been mentioned that the final concentration of c-di-GMP in a cell with BphSOpti is determined by the 
combined and antagonistic action of the cyclase and the phosphodiesterase. The latter is required to 
maintain low levels of c-di-GMP in the dark. So one possible explanation for the lack of light regulation 
could be that the dark activity of the enzyme is not compensated by the phosphodiesterase. The capacity of 
this enzyme might be overloaded already by the dark activity of the enzyme. In this case it may not be able 
A 
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to keep up with the activity of the BphS enzyme with the effect that a difference in c-di-GMP between light 
and dark may be masked. To understand the contribution of the phosphodiesterase to the final 
concentration of c-di-GMP, the experiments were repeated with a construct which lacked the 
phosphodiesterase. If the aforementioned hypothesis is correct elimination of the phosphodiesterase 
should generate a positive bias for an increase in c-di-GMP concentration as a result of BphS activity. In  this 
case it might be possible to detect a small amount of un-cleaved nucleotide. 
To eliminate YhjH from the construct, the plasmid was double-digested with two restriction enzymes 
cutting right before YhjH and after the stop codon of the TdTomato. The linearized plasmid was separated 
from the other fragment by gel electrophoresis and purified. A TdTomato was then inserted in the plasmid 
via AQUA cloning after the 2A of BphS. The new plasmid was transfected into Jurkat cells, which were then 
treated and analyzed as in Fig. 4.20. The analysis of the fluorescence intensities is reported in Fig 4.22. In 
both experimental conditions namely with cells kept in the dark (A) or exposed to light (B) the red and 
green fluorescent signals were again linearly correlated. In cells kept in the dark or exposed to light the 
slope of the curve was 14.2 ± 0.2 (N=19) and 14.8 ± 2 (N=20), respectively. Notably there is no difference 
between the two values indicating again an absence of light sensitivity of the BphS  enzyme. Moreover, the 
slope values are not bigger than that calculated for the experiments in which the YhjH was present and are 
indeed similar to that of Slr1143 R250A from the same set of measurements. This suggested that the 
presence/absence of the phosphodiesterase has no impact on the synthesis of the IFN-β reporter and 
hence on c-di-GMP production. 
 
 
Fig 4.22 Estimation of the impact of YhjH on the BphSOpti system. (A) I.D. values for the green signal (IFN-β) measured in cells 
transfected with only BphS and kept in the dark, plotted as a function of the I.D. values for the red signal (TdTomato). (B) I.D. values 
for the green signal (IFN-β) measured in cells transfected with only BphS and exposed to light for 1.5 hours, plotted as a function of 
the I.D. values for the red signal (TdTomato). Data points in (A) and (B) are fitted with a linear equation (grey and red). 
A  B  
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4.5 Additional information 
In the following tables are reported the  parameters of the non-linear curve fitting showed in the figures. 
Fig. 4.1 c – black  A1 1,0147 ± 0,01378 Fig. 4.14 A  A1 -0.47379 ± 0.16305 
 A2 -0,01693 ± 0,01138  A2 -2.54816 ± 0.09327 
 x0 -109,97454 ± 0,75614  x0 5.91888 ± 0.82498 
 dx 13,28941 ± 0,71979  p 1.34424 ± 0.26839 
Fig. 4.1 c – blue A1 1,00847 ± 0,00995 Fig. 4.15 A A1 0.73049 ± 1.61478 
 A2 0,00136 ± 0,00646  A2 -2.05559 ± 0.23558 
 x0 -117,97529 ± 0,48109  x0 1.95145 ± 2.61152 
 dx 11,21268 ± 0,43482  p 0.80597 ± 0.46069 
Fig. 4.6 c – black A1 0,99509 ± 0,01594 Fig. 4.16 A A1 -0.43861 ± 0.2363 
 A2 -0,01931 ± 0,01603  A2 -2.29407 ± 0.08261 
 x0 -97,68674 ± 1,03118  x0 3.9242 ± 0.76701 
 dx 12,54811 ± 0,94175  p 1.76725 ± 0.51808 
Fig. 4.6 c – blue A1 1,00928 ± 0,01307 Fig. 4.17 B black A1 1.01795 ± 0.01017 
 A2 -0,01016 ± 0,00994  A2 0.00257 ± 0.00657 
 x0 -107,53026 ± 0,71036  x0 -104.13818 ± 0.45094 
 dx 11,4975 ± 0,64951  dx 9.66888 ± 0.40686 
Fig. 4.6 c – black dashed A1 1,01745 ± 0,01367 Fig. 4.17 B red A1 1.01674 ± 0.01044 
 A2 -0,00936 ± 0,01505  A2 0.00115 ± 0.00712 
 x0 -87,35274 ± 0,80934  x0 -102.81618 ± 0.47116 
 dx 10,99424 ± 0,75135  dx 9.41143 ± 0.42393 
Fig. 4.6 c – blue dashed A1 0,99993 ± 0,01539 Fig. 4.17 B violet A1 1.01632 ± 0.01257 
 A2 0,00318 ± 0,01593  A2 0.00329 ± 0.00978 
 x0 -89,06617 ± 0,88237  x0 -99.88526 ± 0.58078 
 dx 9,78787 ± 0,80604  dx 8.03066 ± 0.49958 
Fig. 4.8 - black A1 1,02227 ± 0,00941    
 A2 0,00209 ± 0,00581    
 x0 -105,57471 ± 0,40269    
 dx 9,45922 ± 0,36278    
Fig. 4.8 - red A1 1,01238 ± 0,0132    
 A2 -0,00611 ± 0,01004    
 x0 -106,18536 ± 0,71841    
 dx 11,6219 ± 0,66027    
Fig. 4.10- black A1 1,00937 ± 0,00589    
 A2 0,00155 ± 0,00465    
 x0 -97,83592 ± 0,29465    
 dx 9,80697 ± 0,26261    
Fig. 4.10- red A1 1,00826 ± 0,01326    
 A2 1,74859E-4 ± 0,0105    
 x0 -97,19258 ± 0,67851    
 dx 10,63125 ± 0,61575    
Fig. 4.10- brown A1 1,01414 ± 0,01697    
 A2 0,01193 ± 0,01229    
 x0 -100,27211 ± 0,82441    
 dx 10,16516 ± 0,74177    
Fig. 4.10- violet A1 1,01048 ± 0,01215    
 A2 0,00112 ± 0,01037    
 x0 -94,63032 ± 0,65408    
 dx 11,38391 ± 0,60538    
Fig. 4.12- black A1 0,99623 ± 0,01526    
 A2 6,90877E-4 ± 0,01184    
 x0 -99,75144 ± 0,72334    
 dx 8,24174 ± 0,62471    
Fig. 4.12- red A1 1,00374 ± 0,00615    
 A2 4,02983E-5 ± 0,00493    
 x0 -99,00137 ± 0,28881    
 dx 7,69234 ± 0,24222    
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From the results obtained so far it is possible to draw some conclusions about the functionality of the 
tested constructs. The experiments in which the HCN4 channel and the constitutive Slr1143 enzyme were 
co-expressed in HEK239T cells clearly show that the latter results in a measurable increase in c-di-GMP in 
these cells an that this elevated levels of the ligand affect the voltage dependence of the HCN4 channel. 
The increase in c-di-GMP concentration in Slr1143 expressing cells was confirmed by two independent 
methods and the left shift of the activation curve of HCN4 between Slr1143 expressing cells and control 
cells is significant. The coincidence between an elevated concentration in c-di-GMP and a modulation of 
HCN4 gating strongly supports previous reports, which advocated cyclic di nucleotides binding to HCN4 and 
a consequence on channel gating (Lolicato et al. 2014). The present data further advocate a correlation 
between the catalytic activity of the enzyme and a shift of the voltage dependence of HCN4. The data show 
that an improvement in the synthesis of c-di-GMP by the mutation R250A in the Slr1143 enzyme, causes an 
increase in the number of measurements in which the activation voltage of HCN4 is negative shifted with 
respect to the control. All this contradicts the results from an other publication in which no binding of cyclic 
di-nucleotides to the channel was observed (Hayoz et al., 2017). 
While the present data confirm a previous report on an interaction of c-di-GMP with the HCN4 channel 
(Lolicato et al. 2014) they reveal also some differences to the latter study. The aforementioned study 
reported that c-di-GMP did not modulate the channel at endogenous physiological concentration of cAMP 
in HEK293T cells; in their measurements c-di-GMP was only effective in reverting the effect of additionally 
added cAMP. In contrast to these data the present recordings show already an effect of c-di-GMP on HCN4 
gating with basal physiological cAMP concentrations. The reason for the different results of the two studies 
might be related to the different type of experiments. While c-di-GMP was continuously synthesized in the 
present study it was added together with or without cAMP via the patch pipette in the study by Lolicato 
and coworkers (Lolicato et al. 2014). Based on the two different experimental systems, the following 
hypothesis could be formulated. Cells have a basic level of cAMP, which determines the position of the 
activation curve of HCN4 channels. With a continuous synthesis of c-di-GMP -as in the present study- the 
V1/2 value is left shifted with respect to control cells, which do not synthesize the cyclic dinucleotide. During 
a whole-cell recording the concentration of cAMP and of c-di-GMP presumably decrease together as a 
result of a perfusion from the patch pipette. The V1/2 value is, at any time, reflected by the concerted 
activity of both agents. The situation is different in the setting used by Lolicato and co workers (Lolicato et 
al. 2014). In their case c-di-GMP was dyalized into the cell while cAMP was already diluted out. It is 
reasonable to assume that the delayed arrival of c-di-GMP at its binding site with the concomitant decrease 
in cAMP concentration masks any effect of the cyclic dinucleotide on HCN4 gating. One aspect of this 
hypothesis deserves further thinking. In a recent paper, the HCN4 channel was exposed to a synthetic 
peptide that stabilizes the unbound conformation of the CNBD (Saponaro et al., 2018). In the presence of 
the peptide and 10 uM cAMP, they observed that the V1/2 was exactly the same as the control cells, i.e. 
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without the peptide and the cAMP. The observed backshift of the activation curve suggested that the 
peptide was able to counteract the effect of cAMP. Interestingly, the fact that the measured V1/2 was not 
more negative than the controls implies that in an HEK293T cell endogenous cAMP is not so crucial in 
determining the activation voltage of the HCN4. So another possible explanation of the observed effect 
may consider the fact that the c-di-GMP has always been present during the formation of the channel. This 
may cause an alteration of the voltage dependence that is independent from the endogenous cAMP. This 
second hypothesis implies an effect of c-di-GMP and CLP that has not been observed so far. For this reason, 
before further speculating, it is more reasonable to test whether the direct effect of c-di-GMP on HNC4 
gating is actually due to the relative dilution timing of the two messengers. This can be done in further 
experiments by performing measurements with perforated patches. 
Dilution problems may be an explanation also for the fact that the ability to counteract cAMP effect 
seemed to be concentration dependent. In Lolicato et al. (2014), the c-di-GMP and the cAMP were 
delivered via the pipette into the cytoplasm together. In the present experiments, on the contrary, the 
whole-cell configuration causes a decrease in the concentration of the cytoplasmatic c-di-GMP, while the 
concentration of cAMP is increasing. In the present study it was possible to measure a backshift of the 
activation curve by a few mV only with non-saturating concentrations of cAMP in the recording pipette. The 
results of these experiments suggest that the recordings conditions and the perfusion of the cells with 
second messengers can be crucial for the response of the cells. 
More conclusions from this study can be drawn about the synthetic phytochrome BphS and its antagonist  
YhjH. The data show that the combined BphS-YhjH system is not properly light-regulated. Both the ELISA 
assays and immune fluorescence measurements reveal a high dark activity of the system. Both assays were 
unable to detect any difference in the c-di-GMP concentration between cells kept in the dark or exposed to 
stimulating red light. Moreover both assays indicate that the c-di-GMP concentration in cells expressing 
BphS-YhjH was about the same as in cells expressing the constitutively active enzyme Slr1143. It is well 
known that the light regulated BphS enzyme is leaky meaning that it also synthesizes c-di-GMP in the dark. 
For this reason it is generally co-expressed with the phosphodiesterase YhjH, which should balance the c-di-
GMP production in the dark. This means that the actual c-di-GMP concentration in a cell is a delicate 
equilibrium between c-di-GMP synthesis and destruction. In this scenario an elevated c-di-GMP 
concentration in the dark could result from an insufficient activity of the phosphodiesterase. This 
interpretation is indirectly supported by the present data. In experiments in which BphS was expressed 
without the YHjH phosphodiesterase, the resulting c-di-GMP concentration was not much different 
compared to cells in which both enzymes were co-expressed. The results of these experiments imply that 
the YHjH phosphodiesterase is not sufficiently active for balancing the dark activity of the BphS cyclase. In 
the case of a large dark background in c-di-GMP synthesis it is not surprising that red light is not able to 
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stimulate an elevated level of the second messenger. The data strongly suggest that the expression and/or 
function of the YHjH phosphodiesterase needs to be improved in order to make this system suitable as an 
optogenetic tool.  
The prominent dark activity of the BphS cyclase and the concomitant elevated c-di-GMP concentration in 
these cells predict that also the activation curve of HCN4 should be shifted in these cells with respect to 
non-transfected controls. This predicted shift however is not detected in the present experiments. The 
voltage dependence of the HCN4 channel in HEK293 cells was not different between cells co-transfected 
with Bphs-YhjH and control cells. The result of these data cannot be finally explained here. However, a 
comparison between the different panels in Fig. 4.20 may suggest a possible explanation of the 
conundrum. The fluorescent values on the x-axis of graphs A, B and E, which are an indirect measure of the 
expression levels for the cyclases, show that the Slr1143-IRES-TdTomato reaches higher maximal expression 
levels than the BphS-2A-YhjH-2A-TdTomato construct. For patch clamp experiments with HEK293 cells 
expressing Slr1143 always the brightest cells were chosen for measurements. Based on the data of Fig. 4.20 
it is reasonable to assume that these cells were also those with the highest concentration of c-di-GMP. 
Hence the shift of the activation curve from Slr1143 expressing cells may be generated by high 
concentrations of c-di-GMP. The electrical experiments with BphS-2A-YhjH expressing cells were done in a 
different manner. In this case the cyclase/phosphdiestearse were co-transfected with a plasmid containing 
GFP. In this case the fluorescence intensity is not a measure for the expression of the cyclase. In this 
scenario it is reasonable to speculate that cells were choses for the electrical recordings in which the  
BphS/YhjH expression was not optimal and hence the c-di-GMP concentration below a functional 
concentration threshold. In further experiments it will be necessary to measure HCN4 channel gating in 
Slr1143 and BphS-2A-YhjH expressing cells with the same protocol. Based on the data from Fig. 4.20, which 
suggest a large range of expression between individual cells and a linear correlation between cyclase 
expression and c-di-GMP concentration, the fluorescent tagged cyclase would be the method of choice.  
The large cell to cell variability (Fig. 4.20) also implies that a much larger of cells has to be measured in 
patch clamp experiments for a robust insight into the effect of the cyclase activity on HCN4 activity.  
The main goal of the present study was the development of an optogentic tool, which is able to modulate 
HCN4 activity by penetrating red light. The present work does not provide such a tool but presents some 
major advances. The data strongly support that a precise regulation of c-di-GMP concentration by red light 
requires a better compensation of the dark activity of the BphS enzyme. It has been shown in previous 
studies that a tuning of the expression of YhjH is crucial for obtaining this desired effect (Ryu et al., 2014). 
In the present study, YhjH is not contributing to the final concentration of c-di-GMP neither in cells kept in 
the dark nor in those exposed to red light. It is therefore reasonable to think that the expression of the 
phosphodiesterase must be increased.  
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One approach to achieve this goal could be obtained by transfecting a different amount of DNA for the two 
proteins. For this purpose YhjH could be moved to a different plasmid, under the same promoter. In this 
way one plasmid will contain only BphS and the other only YhjH. The two plasmids could be transfected 
together into HEK293T by using different concentrations for each plasmid. For example the DNA for BphS 
and YhjH could used in a 1:2 or 1:3 ratio in co-transfections. By optimizing this ratio it might be possible to 
find a good balance between the two antagonistic enzymes and to achieve a robust increase in c-di-GMP 
concentration in response to light. 
An alternative approach could involve the tuning of protein synthesis, taking advantage of the work by 
Ferreira and colleagues (Ferreira et al., 2013). These authors show different ways by which it is possible to 
decrease the translation of a gene of interest. In one strategy the translation initiation site (TIS) could be 
modified. This is a short sequence, which is recognized by the ribosome and is composed of three bases 
upstream the methionine, the start codon and the first base after it. Many human genes present the 
conserved motif (G/C)CCAUGGG as a TIS. The insertion of an UUU triplet right before the start codon 
causes a decrease in the expression of the protein up to -50%. In this way it might be possible to favour the 
expression of the phosphodiesterase over the cyclase. For a more fine regulation of the translation levels, a 
small ORF, coding for only two amino acids, can be inserted 5 bases upstream the gene of interest (uORF). 
By using different combinations of triplets before the start codon of the target gene and of the uORF, it is 
possible to decrease the synthesis of a protein from-50% to -99%.  
In addition to the previous method, which increase the activity the phosphodiesterase over the cyclase, 
also improvement in the light sensitivity of the cyclase could help in the construction of the desired 
optogenetic tool. Such a cyclase with an higher light-dependent activity, was recently developed by the 
group of Prof. Gomelsky at the Wyoming University (unpublished data). In further work this protein might 
be expressed at a very low concentration in cells. The dark activity of this protein might then be better 
compensated by YhjH. Because of the increased light sensitivity the improved cyclase might then produce a 
sufficient rise in c-di-GMP concentration for modulation of HCN4 gating.  
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6.1 Molecular Biology 
PCRS 
PCRs were performed for different purposes: insertion of mutations, preparation of inserts for cloning, 
screening of colonies by colony-PCR. Two thermal cyclers have been used in this work: BioRad Tm100 and 
Biolab Cycler48 (Bio-Rad, Hercules, CA, USA; Biolab, Bebensee, Germany). The polymerases for the 
reactions were Phusion and Taq from ThermoFisher (Waltham, MA, USA) and NEB (Ipswich, MA, USA). All 
the reactions were prepared according to the manufacturer’s instructions. For GC-rich sequences, the 
appropriate buffer was used. When DMSO was needed, its final concentration never exceeded 3%. The 
oligonucleotides (Sigma-Aldrich, St. Louis, MO, USA) were diluted in sterile ddH2O to a final concentration 
of 100 uM and kept at -20 °C. 
Phusion polymerase was used to amplify a gene of interest, to add flanking sequences or for overlapping 
PCRs. The thermal cycler protocols were designed according to the instructions provided with the enzyme. 
The 3-steps protocol, with annealing temperature at Tm - 4°C, worked well in most of the cases. All the PCR 
products were separated by gel electrophoreses on 0.8-1% agarose gels with 0.6 μg/mL MidoriGreen in 1x 
TAE (Tris-Acetate-EDTA) buffer. The DNA was then gel-purified and quantified as described below. 
Taq polymerase was chosen for colony-PCRs. Colonies were picked with a pipette tip and re-suspended in 
10 µL of sterile ddH2O. 1 µL of each cell suspensions was then added to the reaction mixtures, while the 
rest was left at 4°C. Thermal cycler 3-steps protocols were designed according to the manufacturer’s 
instructions. Once the positive colonies were determined by gel electrophoreses, the respective cell 
suspensions were re-inoculated in 8 to 130 mL of LB (Luria-Bertani) medium with appropriate antibiotic 
selection and grown for 16 hours (250 r.p.m. at 37°C) for mini/midi preparations (see below). 
GEL EXTRACTION 
The bands of interest (PCR products or linearized plasmids) were cut out from agarose gels using an 
ethanol-sterilized scalpel and transferred into 2 mL reaction tubes. Two different kits have been used in this 
work: Zymoclean Gel DNA Recovery from ZymoResearch (Freiburg, Germany) and QIAquick PCR & Gel 
Purification Kit from Quiagen (Hilden, Germany). The protocols of the two kits are the same: 
1) Three volumes of the appropriate buffer (e.g. for 100 mg of gel slice 300 µl of buffer) were added to the 
gel slices and the latter were melted at 50-55°C for 10 minutes. 2) The gel slices melted in the buffer were 
loaded onto purification columns provided with the kit. 3) The columns were centrifuged for 1-2 minutes at  
> 13000 x g (Sigma centrifuges, model 1-14) and the flow-through was discarded. 4) Columns were then 
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washed with the indicated buffer and centrifuged at 13000 x g. 5) The DNA was eluted with the 
recommended volume of water. DNA concentration of the samples was determined as described below. 
DNA CONCENTRATION QUANTIFICATION 
DNA sample concentration was determined with a UV-Vis spectrophotometer (NANODROP ONEC from 
ThermoFisher, Waltham, MA, USA). Water was used for the blank measurement; the same volume of DNA 
samples was next loaded on the spectrophotometer. The drops of blank and DNA samples form a liquid 
column of known height between two pedestals. Light from a xenon flashlamp passes through this column 
and is detected by the internal spectrometer. A graph with the absorbance of the sample as a function of 
the wavelengths appears on the screen within few seconds, together with a table containing the 
concentrations of the samples in ng/µL, the 260/280 ratio and the 260/230 ratio. 
TRANSFORMATION OF COMPETENT BACTERIAL CELLS 
DNA was transformed in competent E. coli cells (Dh5α strain) via heat shock. 10 ng DNA was added to 50 µL 
of competent cells and the mixture was incubated on ice for 30 minutes. Afterwards, the cells were left at 
42°C for 1 minute (dry bath) and then brought back onto ice for 5 minutes. 200 µL LB medium without 
antibiotics was added to the cells and the incubated on a shaker at 250 rpm for 30 minutes at 37°. Cell 
suspensions were centrifuged at 4000 rpm (Sigma centrifuges, model 1-14) for 4 minutes and almost all the 
medium was discarded. Cells were resuspended in the small volume of medium, which remained in the 
tube (  50 µL) by gently tapping the pellet. The re-suspended cells were then spread on a petri dish 
containing solid LB-Agar (15 g Agar/1L LB) and the appropriate antibiotic. Cells were grown overnight (16 
hours) on the LB-Agar layer. 
DNA EXTRACTION FROM BACTERIAL CELLS 
Plasmid DNA purification from E.coli cultures was done with miniprep or midiprep kits. For minipreps were 
used two kits: GenElute Plasmid miniprep kit from Sigma-Aldrich (St. Louis, Missouri, USA) and ZR plasmid 
miniprep kit from Zymo (Freiburg, Germany). For midipreps, NucleoBond Xtra Midi kit from Macherey-
Nagel (Duren, Germany) was employed. Cells taken from a colony or a glycerol stock were grown for 16 
hours in 8 mL (miniprep) or 130 mL (midiprep) of LB medium (37°C, 250 rpm). The first passages of the two 
protocols are basically the same and they include: centrifugation of the cells, resuspension of the cell pellet, 
alkaline lysis at room temperature (RT) for 2-5 min and termination of the alkaline lysis with a 
neutralization buffer. After this procedure a precipitate of cell debris is visible. The following steps are 
different between miniprep and midiprep protocols. For a midiprep, the lysate is first passed through a 
filter (provided with the kit) in order to eliminate cell debris, before going on a purification column (also 
provided with the kit). The filter and the column were both washed with the proper buffers and then the 
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DNA was eluted. The DNA is mixed with 0.7 volumes of 2-propanol for precipitation. After a centrifugation 
(15000 x g for 30 minutes at 4 °C, BIOFUGE primoR), the DNA pellet was dried at room temperature and 
resuspended in ddH2O. For minipreps, the cell debris were eliminated by centrifugation and only the 
supernatant was loaded on a purification column. The columns were then washed with the indicated buffer 
and the DNA was finally eluted with the recommended volume of water. DNA concentration was 
determined as previously described. 
PLASMIDS DIGESTION WITH RESTRICTION ENZYMES 
DNA digestions have been performed by using FastDigest restriction enzymes (FD) from ThermoFischer 
(Waltham, MA, USA). These products have two important advantages: 1) different enzymes can work in 
the same buffer, 2) the reaction time is very short (1 µg of plasmid DNA can be digested in 5-10 minutes). A 
reaction mix of 20 µL included: 2 µL of 10x FDGreen buffer + 1 µg DNA + 1 µL enzyme + ddH2O up to 20 µL. 
The reaction mixtures were incubated at 37°C for 5-10 minutes in a dry bath. FD Green Buffer includes a 
density reagent and two tracking dyes; the reactions were therefore directly loaded on an 1% agarose gel 
with 0.6 μg/mL Midori Green in 1x TAE buffer for electrophoreses. After checking the digestion result, a gel 
extraction was performed as previously described. 
ENZYME-FREE CLONING 
For this project I decided to use an enzyme-free cloning approach called AQUA cloning (Beyer et al., 2015). 
This DNA assembly method relies on in vivo processing by E. coli: homologous recombination allows the 
generation of circular plasmids from DNA fragments sharing overlapping homologous regions (a cut 
plasmid and inserts). The gene of interest was amplified by PCR and regions of homology to a linearized 
expression vector were introduced. Primers were designed to add flanking regions of 32 bp upstream and 
downstream. The PCR products were separated by gel electrophoreses on 0.8-1% agarose gel with 0.6 
μg/mL MidoriGreen in 1x TAE buffer and gel extraction was performed as described before. Plasmids were 
linearized using FD restriction enzymes from Thermo Fisher (Waltham, MA, USA) and gel-purified. The DNA 
fragments (expression vector and insert) were then mixed in a 1.5 mL tube as follows: 
 
Linearized plasmid 12 ng / Kb plasmid 
Insert molar ratios of 3:1 (insert:vector) 
H2O up to 10 µL 
Final Volume 10 µL 
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The DNA mixture was incubated for 30 minutes at RT and 30 minutes at 50°C. The DNA was then added to a 
50 µL aliquot of competent DH5α cells. The tubes containing the DNA-cell mixture were kept on ice for  30 
minutes, after which a heat shock was performed. The reaction tubes were therefore transferred for 45 
seconds to a dry bath at 42°C before transferring them back on ice for 10 more minutes. At this point 500 
µL of LB medium was added to the cells, which were incubated on a shaker (250 r.p.m.) for 1 hour at 37°C. 
After a quick centrifugation (4000 x g for 4 minutes Sigma centrifuges, model 1-14), most of the medium 
was discarded and the cells were resuspended in    50 µL of LB. The small volume of medium with re-
suspended cells was then spread on LB-agar plates containing appropriate antibiotics. The next day the 
colonies were screened via colony-PCR. Positive colonies were re-inoculated in LB medium with appropriate 
antibiotic selection and grown for mini/midiprep. The DNA was then sequenced by EurofinsGenomics 
(Luxembourg).  
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6.2 HEK293T cells culture and transfection 
HEK293T CELL LINE MAINTENANCE 
HEK293T cells were cultured in DMEM (Dulbecco’s Modified Eagle Medium, Euroclone, Pero, Italy) and 
DMEM/F-12 (1:1 mixture of Dulbecco's Modified Eagle Medium and Nutrient Mixture F-12, Millipore, 
Burlington, MA, USA) supplemented with 10% fetal bovine serum and 1% Pen Strep (100 U/mL of penicillin 
and 100 µg/ml of streptomycin), both from Sigma-Aldrich. Cells were grown in 25 mm2 flasks (Sartstedt, 
Numbrecht, Germany), stored in a 37 °C humidified incubator with 5% CO2. DMEM/F-12 without phenol-
red was used for experiments with red light. Cells were split every 3-4 days. After the medium was 
removed, 1 mL of trypsin or accutase (both from Sigma-Aldrich, St. Louis, MO, USA) was added. Cells were 
then incubated for 2 minutes at RT with trypsin or 4 minutes at 37 °C  with accutase. The enzymatic 
reaction was stopped by adding 5 mL of fresh and pre-heated medium. The desired amount of cell 
suspension was added to a new flask pre-filled with 5 mL medium. The same cell suspension was also used 
to seed the cells in 35 mm petri dishes (Sartstedt, Numbrech, Germany) pre-filled with 2 mL of fresh 
medium. The latter cells were used for transfections. After 25 to 30 passages, the transfection efficiency 
started to get worse. At this point new cells were thawed from a stock to start a new line. HEK293T cell 
stocks were stored as aliquots in liquid nitrogen with medium and DMSO. When an aliquot was thawed, the 
cells were immediately centrifuged to separate them from DMSO. The pellet was re-suspended in 1mL of 
fresh medium and transferred to a new flask containing 5 mL of fresh medium. 
TRANSFECTION OF HEK293T CELLS 
Two transfection protocols have been used in this work for HEK293T cells. 
1. Turbofect transfection protocol. The following transfection mix was prepared in a 1.5 mL reaction tube: 
100 µL of serum-free medium, up to 1µg of each plasmid, 2µL of turbofect/µg DNA (turbofect transfection 
reagent from ThermoFisher, Waltham, MA, USA). The transfection mix was vortexed and incubated at RT 
for 20 minutes. After these 20 minutes the transfection mix was added drop-wise to petri dishes with a cell 
confluence between 60% and 80%. The dishes were gently shaken to achieve even distribution of the 
transfection mix. This transfection method does not require changing of the medium. 
2. Calcium phosphate transfection method. Two 1.5 mL tubes were prepared. The first one was filled with 
500 µL of 2x Hepes Buffer Solution (280 mM NaCl, 50 mM HEPES, 1.5 mM Na2HPO4, pH 7.09 with 5M 
NaOH). The second tube was filled in the following order: up to 6 µg of each plasmid, 62 µL CaCl2 2M, H2O 
up to 500 µL. The content of this tube was added drop-wise to the first one, while gently tapping the latter 
to ensure good mixing. After incubation at RT for 10 minutes, 500 µL of the transfection mix was added in a 
35 mm petri dish with a cell confluence between 60% and 80%. Cells were transferred back into the 
incubator and the medium was changed after 4 hours. 
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6.3 Jurkat cells culture and transfection 
JURKAT CELL LINE MAINTENANCE 
Jurkat cells were cultured in RPMI (Roswell Park Memorial Institute 1640 medium, Millipore, Burlington, 
MA, USA) supplemented with 10% fetal bovine serum and 1% Pen Strep (100 U/mL of penicillin and 100 
µg/ml of streptomycin), both from Sigma-Aldrich. Cells were grown in 75 mm2 flasks (Sartstedt, Numbrech, 
Germany), stored in a 37 °C humidified incubator with 5% CO2. RPMI without phenol-red was used for 
experiments with NIR. 
The cells were split every four days. Jurkat are not adherent cells so they don’t need to be detached from 
the flask with enzymes. A new flask was prepared with 15 mL of fresh pre-heated medium, then 15 mL of 
the cell culture was transferred to this new flask. The cells were visually checked with a microscope 
periodically. Healthy Jurkat cells appear round, with small wing-shaped extensions. When the cells started 
to look unhealthy (not round and without extensions) a new line was started as described for HEK293T.  
TRANSFECTION OF JURKAT CELLS 
Jurkat cells are more difficult to transfect than HEK293T cells. For the present work I used a protocol, which 
had been established in previous work (Voos et al. 2018). The transfection reagent used in this protocol is 
lipofectamine 2000 (Invitrogen, Carlsband, CA, USA). 
The cell concentration in the culture flask was determined with a cell-counter (NanoEnTek, Seoul, Korea). 
An aliquot of 50 µL of cell culture was mixed with 50 µL of Tryphan Blue, which stains dead cells. 10 µL of 
this blue sample was loaded on a counting slide for inspection in the cell counter. The counter provides 
information about cell concentration and viability. For transfections, 1.4 – 1.7 x 106 cells were pelleted and 
re-suspended in 100 µL of fresh pre-heated medium. In another 1.5 mL tube, 1µg of DNA (for double 
transfections 0.5 µg of each DNA) was mixed with 6 µL lipofectamine 2000. After 5 minutes of incubation at 
RT, 250 µL of serum-free medium was added. After one more minute of incubation at RT, the transfection 
mix was transferred in the first tube to be mixed with the cells. This tube was then incubated at 37°C for 5 
hours, after which the cells were seeded in 35 mm petri dishes together with 2 mL of fresh medium.  
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6.4 Electrophysiology 
24 hours after transfection, HEK293T cells were split in 35mm petri dishes to obtain dispersed single cells. 
After 3-4 hours cells were ready for patch-clamp experiments, which were performed at RT. 
EXPERIMENTAL SETUP AND ANALYSIS 
For experiments at TU Darmstadt the glass pipettes were prepared with a vertical puller (model P-P 830 
from Narishige, Suginami, Japan). Borosilicate capillaries (1.5-1.8 x 1000 mm, Kimble, Vineland, NJ, USA) 
were pulled and then coated with Sigmacote (Sigma-Aldrich, St. Louis, MO, USA). The capillaries were then 
dried for 5 to 6 days. For recordings at the University of Milan, a horizontal puller (P-97 Flaming/Brown 
from Sutter, Novato, CA, USA) was used to pull borosilicate capillaries (1.5mm O.D., 0.86 I.D. capillaries 
from Sutter, Novato, CA, USA). Both pullers were set to obtain pipettes with a resistances of 3–5 MΩ. 
Pipettes were filled with the intracellular solution, which contained: 10 mM NaCl, 130 mM KCl, 1 mM 
egtazic acid (EGTA), 0.5 mM MgCl2, 2 mM ATP (Mg salt) and 5 mM HEPES–KOH buffer (pH 7.4). Where 
indicated, Adenosine 3′,5′-cyclic monophosphate (cAMP, Sigma-Aldrich) was added to the intracellular 
solution. The medium was removed from the 35 mm petri dish before recordings and substituted with the 
extracellular solution, which contained: 110 mM NaCl, 30 mM KCl, 1.8 mM CaCl2, 0.5 mM MgCl2 and 5 mM 
HEPES–KOH buffer (pH 7.4). 
Fluorescent cells were approached with the glass pipette and sealed against the pipette tip by gentle 
suction. After obtaining a good seal (seal resistance > 1GΩ), HCN4 currents were measured in the whole-
cell configuration. In Milan a Dagan 3900A amplifier (Degan, Minneapolis, MN, USA) and an Axon Digidata 
1322 A/D converter (Axon Instruments, San Jose, CA, USA) were used for the recordings. The recorded 
current traces were analyzed with Axon pClamp9. In TU Darmstadt the same measurements were 
performed with a HEKA EPC9 (HEKA, Lambrecht/Pfalz, Germany), which includes in a single instrument the 
amplifier and the A/D converter. Currents were in this case analyzed with PatchMaster v2x90.2 a software 
from HEKA. To elicit and record HCN4 currents voltage step protocols were applied to the cells. Each 
protocol was composed by many cycles, each of them divided in 3 segments. In the first and the last 
segment the voltage was clamped at -30 mV (1 second) and -40 mV (7 seconds), respectively. Test voltages 
were applied in the second segment (4.5 seconds), starting from -30 mV, in -15 mV increments. Usually, 
protocols were composed of 10 cycles to cover a range of voltages from -30 to -165 mV. 
The current traces were analyzed to investigate the voltage dependence of the channel. In the Results and 
Discussion chapters, I explain the types of analysis that I performed and the rationale behind them. The 
analysis and the preparation of the figure were done with the Originpro (OriginLab, Northampton, MA, 
USA) or Igorpro (WaveMetrics, Lake Oswego, OR, USA). 
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6.5 ELISA assays for quantification of intracellular c-di-GMP 
PREPARATION OF CELL EXTRACT SAMPLES 
ELISA assays were performed in order to quantify the intracellular c-di-GMP concentration. For this purpose 
cell extracts had to be prepared. Cells were transfected with the constructs of interest and after 24 hours 
the transfection efficiency was checked under a microscope (usually 30-40 % of transfected cells). Cells 
were detached from the dishes with accutase and the reaction was stopped with 2mL medium. Cells were 
transferred into a 2 mL tube and centrifuged (800 x g, 3 min, BIOFUGE, primoR); the supernatant was 
discarded. For the lysis of the collected cells three methods for different assays were used during the 
course of this work. The reasons for using three different approaches are explained in Results and 
Discussion. The three different methods are as follows:  
1. Cells were resuspended in PBS to a final concentration of 1 x 106 cells/mL. The cell membranes were 
then broken by 3 freeze/thaw cycles.  
2. Cells were resuspended in an 1% Triton buffer (150 mM NaCl, 2 mM EDTA, 1% Triton, 10 mM Tris-HCl pH 
7.4) to a final concentration of 1 x 106 cells/mL. The lysis buffer was added cold to the cell pellets. Cells 
were resuspended by pipetting and vortexing. After that, cells were incubated on ice for 30 minutes. 
3. Cell pellets were resuspended in a buffer containing acetonitrile, methanol and  H2O (2:2:1) to a final 
concentration of 1 x 106 cells/mL. Cells were incubated on ice for 15 minutes and at 95°C for 5 minutes. 
 
The lysates obtained with these methods were cleared of cell debris by centrifugation (5 min, 14000 x g, 
4°C, BIOFUGE primoR). The supernatants were collected and stored at -20°C. 
ELISA ASSAY 
For this work the General Cyclic Diguanylate ELISA Kit (EIAab, Wuhan, China) was used. This assay is based 
on the competitive immunoassay technique. General information about competitive ELISA can be found in 
Results and Discussion, where I introduce this technique. The assay was performed according to the 
manufacturer’s instructions. Before the assay all the reagents were brought to room temperature. Samples, 
standards and reagents were loaded in two replicates in 96-well plate with a multi-channel pipette. The 
incubation steps were performed at 37°C in a sterile incubator. During these incubation steps, the plate 
was carefully sealed to avoid contamination. After each incubation step, the reagents were removed from 
the wells by pipetting plus gently tapping the plate on a paper towel. After the last step of the assay 
procedure, the absorbance values of the wells were measured with a special spectrophotometer designed 
to read multi-well plates (Epoch2 from BioTek, Winooski, VT, USA). Absorbance values of the standards 
were used to obtain a calibration curve, from which concentration values of the samples could be 
extrapolated. For this analysis an online software called MyAssay was used (www.myassays.com). 
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6.6 Immuno-fluorescence of Jurkat Cells 
PREPARATION OF THE CELLS 
As explained in the Results and Discussion, I quantified the production of interferon β (IFN-β) in Jurkat cells 
in response to the presence of c-di-GMP with immunofluorescence. Cells were transfected with the 
constructs of interest as described in chapter 6.2. 24 hours after transfection, the following treatments 
were applied: 
1. Cells were transferred into 2 mL reaction tubes and centrifuged (1800 rpm, RT, 5 minutes, Sigma 
centrifuges, model 1-14). The medium was discarded and the pellet resuspended in 1 mL PBS. After 
centrifugation, the PBS supernatant was removed from the tube. All following centrifugation steps were 
performed as the aforementioned one. 
2. The pellet was resuspended in 1 mL of 4% Paraformaldehyde (in PBS). Cells were incubated at RT for 30 
minutes on a shaker at 400 rpm.  
3. Cells were isolated by centrifugation from the Paraformaldehyde supernatant and resuspended in 1 mL 
of 0.2% Triton X-100 (in PBS). Cells were then incubated on a shaker with Triton X-100 at RT for 10 
minutes (400 rpm). After this incubation the cells were pelleted and the Triton X-100 was discarded. This 
step was repeated twice. 
4. The cells were washed with 1 mL PBS. 
5. After PBS was removed, the cells were resuspended in 0.5 mL of primary antibody (20 µg/mL, anti-IFN-β 
rabbit polyclonal antibody, ThermoFisher), to which they were exposed overnight (16 hours, 4°C, 300 
rpm). 
6. The next day the samples were centrifuged to eliminate the antibody. The cell pellet was resuspended in 
1 mL of Tween20 (Polyethylene glycol sorbitan monolaurate) 0.05% (in PBS) and centrifuged again. 
7. The Tween20 was discarded and substituted with 500 µL secondary antibody (1 µg/mL, AlexaFluo goat 
anti-rabbit, Invitrogen, Carlsbad, CA, USA). Cells were incubated with the antibody for 1 hour, at RT on a 
shaker at 400 rpm. After this incubation the cells were pelleted. 
8. The pellet was washed with 1 mL of Tween20 0.05% (in PBS) and centrifuged. 
9. The cells were resuspended in 500 µL PBS. 
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IMAGING AT THE CONFOCAL MICROSCOPE 
Jurkat cells were imaged on a confocal laser scanning microscope (CLSM) (LeicaTCS SP5; Leica mycrosystem 
CMS GmbH, Wetzlar, Germany). The cell samples were examined using an immersion objective (HCX PL 
APO 100x). Two laser lights were used for exciting the fluorescent tags. The first was an  488 nm Argon laser 
with an intensity of 20%. The second was a green 561 nm laser at intensity of 40%. The filter used for this 
type of analysis was a dual band pass filter (458-514 nm). For the green GFP-like emission signal the 
detector HyD1 was used, while for the red signal was collected by HyD2 detector. Each detector covered a 
range of wavelengths ±20 nm around the absorption peak. The cells were measured in PBS. Each cell 
sample was loaded on a 25 mm coverslip fixed between two aluminum rings. The coverslip was then fixed 
to the microscope plate.  
Images of the cells were taken using the software LAS AF Version 2.60 (Leica Leica mycrosystem CMS 
GmbH). The images were acquired with a scanning frequency of 200 Hz and the pixel size was set to 
1024x1024. Pictures were then analyzed with the software Fiji (Bethesda, MD, USA) to quantify the 
fluorescence intensities. The analysis that was done on the images acquired at the microscope is presented 
in the Results and Discussion part. 
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